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ABSTRACT 
 The presence of bacterial endotoxin in the bloodstream, known as endotoxemia, may 
cause inflammation and play a role in the development of chronic disease. Dietary fatty acid 
composition has been demonstrated, albeit inconsistently in different animal species, to 
modulate endotoxemia potentially via altered lipopolysaccharide (LPS) absorption from the 
intestinal lumen. We first sought to uncover whether postprandial endotoxemia in healthy 
people is influenced by the consumption of meals rich in saturated or long-chain n(ω)-3 fatty 
acids, respectively.  Considering the physiological similarity of the human and porcine 
gastrointestinal tracts, the effect on endotoxemia from long-term consumption of high fat diets 
distinct in fatty acid composition was examined in pigs. Mechanistic investigations were 
performed in porcine tissue in vitro and ex vivo to understand how dietary fatty acids might 
differently regulate LPS transport and LPS-induced inflammation at the intestinal epithelium. 
 Previous studies using human participants have indicated that the consumption of a 
high-fat meal is associated with increased postprandial endotoxemia and circulating markers of 
inflammation. However, it was unclear whether this effect was dependent on high or low fat 
content or the fatty acid composition of the meal. To address this question, healthy adult men 
and women were recruited for a randomized cross-over study in which participants consumed a 
low-fat meal, or one of three high-fat meals containing saturated, n-3, or n-6 fatty acids. Serum 
endotoxin concentration was lower (p<0.05) following the consumption of an n-3 fatty-acid rich 
meal compared to serum endotoxin concentration after the consumption of a saturated fatty 
acid-rich meal.  Postprandial endotoxemia was not different regardless if the participant had 
consumed a low-fat content or high fat content meal. Despite alterations in blood endotoxin, 
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none of the meals was found to impact biomarkers of systemic inflammation.  These results 
suggest the modulatory effect of a high fat meal on blood endotoxin concentration is 
dependent on the fatty acid composition, but not total fat content of a meal. 
 Next, we used a porcine jejunum epithelial cell line, IPEC-J2, to investigate in vitro a 
potential mechanism for common dietary fatty acid mediation of LPS transit across the small 
intestine epithelium where fatty acids are absorbed in vivo. However, our investigation did not 
find LPS to transit across the IPEC-J2 polarized monolayer regardless of the presence of 
saturated, n-3, or n-6 fatty acids. Since chemically-purified LPS does not exist in vivo but is 
instead found within bacterial membrane fragments or in live bacteria, we also sought to 
determine whether the inflammatory effect of purified versus in vivo-relevant forms of LPS 
differently elicit inflammation and if these sources of inflammation are commonly modulated, 
and via what pathway, by dietary fatty acids. We found purified LPS stimulated comparatively 
less (p<0.05) inflammation than native forms of LPS. Moreover, long chain polyunsaturated 
fatty acids inhibited (p<0.05) LPS-induced production of inflammatory cytokines via a TLR4 
pathway, whereas medium chain saturated fatty acids did not alter (p>0.05) the normal 
inflammatory response. These results indicate that purified and native forms of LPS behave 
differently in in vitro cell culture suggesting mechanistic investigations for in vivo uptake of LPS 
from the gut lumen should use in vivo-relevant forms of LPS. 
 Little is known about how long-term consumption of high fat diets that differ in dietary 
fatty acid composition alter endotoxemia. We used a pig model to investigate how daily 
consumption of a low fat, high fat, or high fat diet with n-3 fatty acids over 9 weeks influences 
endotoxemia. An effect of the fat composition of the diet on endotoxemia was not found 
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(p>0.05). Pig jejunum segments were harvested from these animals and mounted in Ussing 
chambers to assess the flux of LPS and live E. coli. It was found that while LPS did not cross the 
intestinal epithelium under any condition, the transit of live bacteria was influenced by diet. 
Significantly more (p<0.05) E. coli transited across jejunum from a high fat diet animal than 
from either a low fat or high fat with n-3 fatty acid animal. This effect was due to the effect of a 
high fat diet in increasing passage of bacteria is mitigated by consumption of n-3 fatty acids via 
a TLR4-dependent pathway. These results suggest the acute modulatory effect of a novel high 
fat meal on postprandial endotoxemia may not persist with repeated consumption of the same 
meal-type. Moreover, endotoxemia from the gut may be related to passage of Gram-negative 
bacteria but not uptake of LPS.  
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CHAPTER 1. GENERAL INTRODUCTION 
Lipopolysaccharide (LPS), a component of the Gram-negative outer cell membrane, is 
generally a potent agonist of the mammalian immune system. The presence of LPS in the 
bloodstream, known as endotoxemia, may serve as an inflammatory stimulus in the 
development of chronic disease. The translocation of LPS from the gut lumen into systemic 
circulation has been suggested to occur under certain conditions of high dietary fat intake (1). 
More recently, the role of dietary fatty acid composition has been proposed as a central 
modulatory factor of the extent to which a high fat diet may, or may not, facilitate luminal LPS 
absorption (2, 3). Saturated and polyunsaturated fatty acids affect immune response to LPS 
through alteration of TLR4 signaling (4). Intestinal epithelial cells express TLR4, the canonical 
mammalian receptor for LPS-induced inflammation, and are involved in uptake of dietary fatty 
acids (5, 6). Localization of TLR4 to the epithelial cell membrane and possibly to the Golgi 
apparatus suggest two fundamental mechanisms by which dietary fat may affect uptake of LPS 
and inflammation. 
Deposit of polyunsaturated fatty acids into the cell membrane is thought to increase 
membrane fluidity and significantly impair TLR4 dimerization, a property essential in the 
induction of TLR4-mediated inflammation (4). Conversely, saturated fatty acids may decrease 
membrane fluidity and enable ligand-independent—that is, without LPS—dimerization of TLR4, 
leading to inflammation (7). The anti-inflammatory and inflammatory effect of polyunsaturated 
and saturated fatty acids, respectively, may play a role in altering integrity of the intestinal 
epithelial tight junctions, potentiating a paracellular pathway through which LPS may 
theoretically migrate into systemic circulation (8, 9).  
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Internalization of LPS and trafficking to the TLR4 receptor located in the Golgi apparatus 
represents a potential transcellular pathway of LPS absorption (10). Since the Golgi apparatus is 
involved in chylomicron formation, as a result of the lipid A region, LPS may be co-packaged 
into chylomicrons (11). Transport of chylomicrons via the lymphatic system into systemic 
circulation may expose the endothelium to immunostimulatory LPS, generating inflammation.  
Although human studies have provided evidence for postprandial endotoxemia, and to 
some extent inflammation, following a high fat meal, it is unknown whether dietary fatty acid 
composition of a high fat meal is the determinant factor instead of a high or low fat content. 
Moreover, mechanistic demonstration of LPS absorption from the gut is largely limited to 
animal or in vitro investigations. Significant limitations abound, however, in translating findings 
from murine and in vitro cell culture to people (12). Although the pig contains numerous 
anatomical and physiological similarities to humans, its use as an animal model is largely 
undervalued (13).  
Likewise, the use of purified LPS to demonstrate a mechanistic in vivo pathway ignores a 
fundamental fact: purified LPS does not exist in vivo. Several studies have illustrated distinct 
physical and chemical differences between purified LPS and native LPS that significantly alter 
recognition and immunological response (14, 15). To what extent common dietary fatty acids 
may differentially modulate inflammation from native LPS instead of purified LPS is unknown.  
To these effects, it is the goal of this dissertation to establish a translational model of 
the effect of dietary fatty acid composition on postprandial endotoxemia in people, and to 
understand the mechanism by which fatty acids modulate LPS absorption from the gut. To 
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satisfy this aim, the following interconnected but not interdependent research objectives were 
undertaken: 
1. To determine the effect of a low or high fat meal, the latter varied in fatty acid 
composition on postprandial endotoxemia and inflammation in people. 
2. To investigate whether purified or native LPS, or live bacteria elicit a common or 
distinct inflammatory response by porcine small intestinal epithelial cells in vitro, and assess a 
modulatory role for dietary saturated or polyunsaturated fatty acids.  
3. To evaluate whether dietary fatty acid composition alters porcine endotoxemia and 
related inflammation in vivo and to identify an intestinal mechanism of small intestine luminal 
LPS uptake ex vivo. 
Dissertation organization 
 Collectively, this work has culminated in the preparation of three manuscripts intended 
for publication in peer-reviewed scientific journals. Bibliographic formatting respective to each 
chapter reflects the journal requirements. The second chapter is a critical review of the 
literature detailing the extent of current knowledge, conceptual and methodological shortfalls 
therein, and potential questions as direction for future research. The third chapter is an 
investigation into the effect of the dietary fatty acid composition of a high fat meal on 
postprandial endotoxemia and systemic markers of inflammation in human participants. This 
chapter has been prepared for submission to British Journal of Nutrition. The fourth chapter is a 
study evaluating the modulatory effect of common dietary saturated or polyunsaturated fatty 
acids upon porcine small intestinal epithelial cells challenged with purified or native LPS, or live 
bacteria. This chapter has been prepared for submission to Molecular Nutrition & Food 
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Research. The fifth chapter is an examination of long-term feeding in pigs of diets distinct in fat 
content or fatty acid composition to determine an effect on endotoxemia and related aspects 
of health in vivo and to assess a mechanism of LPS transport across the gut epithelium ex vivo. 
This chapter has been formatted for submission to Journal of Lipid Research. 
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CHAPTER 2. LITERATURE REVIEW 
 
Abstract 
Lipopolysaccharide (LPS), synonymously referred to as endotoxin, is a component of the Gram-
negative bacterial outer membrane. A substantial literature spanning multiple disciplines and 
dating back over a century has been devoted to the study of LPS. It has been suggested that 
endotoxemia, the presence of LPS in the bloodstream, is a contributing factor to numerous 
chronic diseases, such as atherosclerosis and Parkinson’s.  The presence of endotoxin in the 
bloodstream may result from the uptake of LPS from the intestinal lumen during the 
postprandial period.  The role of dietary fat in modulating postprandial endotoxemia is poorly 
understood although accumulating evidence suggests that intestinal enterocytes may play a 
central mechanistic role.  Dietary-acquired saturated fatty acids are thought to enhance LPS 
translocation, either via a transcellular or paracellular route, while polyunsaturated fatty acids 
reduce translocation. However, in assessing the impact of dietary fatty acid composition on 
blood endotoxin and endotoxemia-associated inflammation distinct outcomes in different 
animal models suggest a species-specific effect. Moreover, in vitro studies that have attempted 
to elucidate a mechanistic basis by which LPS may be absorbed from the gut, have so far relied 
primarily on the use of purified LPS, which does not exist in vivo—and, may therefore not 
model an in vivo uptake pathway or immune response—in distinct cell lines that are not 
involved in dietary fatty acid absorption. This chapter is intended as a critical review of relevant 
literature, with suggestions for future research direction, of the intestinal tract as a site of 
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action where dietary fatty acid composition may modulate LPS transport across the intestinal 
epithelium.  
Introduction 
 Endotoxin, synonymously referred to as lipopolysaccharide (LPS), is a component of the 
Gram-negative bacterial outer membrane (1). Dietary fat has been suggested to modulate 
endotoxin absorption across the intestinal epithelium, thereby altering blood concentrations of 
endotoxin (2, 3). Certain forms of endotoxin elicit an inflammatory response by the human 
immune system. Endotoxemia, the presence of endotoxin in the bloodstream, is a known 
predisposing factor to several chronic diseases (4, 5).  Therefore, dietary fat consumption may 
play a role in modulating certain human chronic disease via chronically elevated blood 
endotoxin. 
 Inflammation, chronic disease, and the postprandial period 
 Cardiovascular disease (CVD), some cancers, and other chronic conditions are leading 
causes of death in the United States (6, 7). Generally, low-grade inflammation that may be 
linked to the progression of some chronic illnesses is thought to be, in part, modulated by diet 
(8). Hence, dietary patterns may help prevent or mitigate the onset or advancement of certain 
chronic diseases.  
Inflammation describes a wide range of actions by different types of cells that 
collectively allow the body to effectively respond and clear select foreign material, 
microorganisms and microbial components such as lipopolysaccharide (LPS), physical injury, 
and other potentially damaging factors. The time from onset of inflammation to the point at 
which it is resolved may be roughly understood in two overlapping but distinct phases, acute 
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and chronic (9). Acute inflammation marks the initiation of inflammation with hallmarks of 
vasodilation such as swelling and increased blood flow, leukocyte recruitment, and the 
production of a range of cellular proteins and substances that propagate immune response. 
Typically, acute inflammation is self-resolved upon clearance of infection or repair of an injury. 
The time-window from which onset to cessation of inflammation is termed, acute, has been 
described to be up to a few weeks (10). Characteristics of the successful resolution of 
inflammation include the site-specific return of monocyte or macrophage levels to pre-
inflammatory concentration, normalization of tissue quality and blood flow, and other factors 
that describe a return to homeostasis. Although the onset and propagator pathways of 
inflammation have been well-studied, relatively little is known how and why inflammation may 
fail to successfully resolve (11, 12). 
 The transition from acute to chronic inflammation may be caused by a dysregulated 
resolution mechanism such as the failed conversion of leukocytes from a pro- to an anti-
inflammatory state, or, more simply, driven by the continuous exposure to the offending 
immunostimulatory molecule. Regardless of what elicits the shift from acute to chronic 
inflammation, a persistent inflammatory state has negative health consequences. The 
continued production of reactive oxygen species or pro-inflammatory cytokines, including 
tumor necrosis factor (TNF)-α, may generate degradation of extra cellular matrices or induce 
cell membrane damage and death (13, 14). Cell death may be a source of damage associated 
molecular patterns (DAMP) that signal continued leukocyte infiltration. Cell-programmed 
apoptosis and caspase-initiated pyroptosis may both be initiated by DAMP and cell-secreted 
chemical mediators. Neutrophil death may release cytosolic contents some of which are 
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antigenic factors recognized by auto-antibodies propagating an immune response (15). 
Progressive loss of tissue quality or negative changes in tissue morphology are characteristic of 
several chronic inflammatory conditions including ulcerative colitis and atherosclerosis. 
Concentrations of inflammatory cytokines and related biomarkers, levels of 
phenotypically pro-inflammatory cells, and other indices of inflammation are used to 
distinguish chronic inflammation in obese individuals, type-2 diabetics, and ill subpopulations 
from the normally-present inflammatory processes and circulating markers in healthy 
individuals (16). However, criteria to further distinguish between levels of inflammation is not 
rigidly defined and may have site-specific rating systems (17, 18). While the distinction between 
high-grade and low-grade inflammation may be relatively clear, low-grade inflammation is 
demonstrated when certain inflammatory biomarkers simply exceed that observed in healthy, 
control populations (19-21).  
Abnormally-elevated acute phase proteins, pro-inflammatory cytokines, and related 
chemical mediators characteristic in low-grade inflammation contribute directly to the 
pathogenesis and mortality of several chronic diseases, including CVD (22, 23). Arterial plaques 
are at an increased risk of rupture following leukocyte infiltration into the arterial endothelium 
(24). Low-grade inflammation has been separately suggested as predictive in the onset of type 
2 diabetes and associated with kidney damage in type 1 diabetics (25, 26). Likewise, the 
persistently-primed state of leukocytes is a contributing cause of renal failure in chronic kidney 
disease (27). A positive association was identified between chronically-elevated inflammation 
and decreased survival rate of some forms of cancer (28, 29). An increased risk of stroke may 
positively associate with ongoing low-grade inflammation (30). 
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Underlying conditions that increase the risk of developing CVD or diabetes, and 
incidence of stroke have been identified as sources of chronic low-grade inflammation. Adipose 
tissue is well-recognized to act as an endocrine organ as adipocytes secrete proinflammatory 
mediators, including TNF-α, and acute phase proteins such as C-reactive protein (CRP) (31, 32). 
35.5% and 35.8% of American adult men and women, respectively, are reported to be obese 
(33). Although the term obesity may be defined as a body mass index of greater than 30 kg/m2, 
it does not distinguish type of body mass to indicate significant accumulation of body fat (33). 
Obesity is not a strong predictive factor of chronic low-grade inflammation as metabolically-
healthy obese individuals do not present an elevated inflammatory phenotype (34). Moreover, 
the site and physical distribution of body fat may also play a role in increasing chronic disease 
risk (35, 36). Nevertheless, leukocyte-adipocyte crosstalk occurs following leukocyte migration 
into adipose tissue. Natural killer cell, other lymphocytes, and macrophage production of 
proinflammatory cytokines within adipose tissue impairs adipocyte insulin signaling and has 
been shown to lead to insulin resistance (37, 38). Insulin resistance in metabolically unhealthy 
obese individuals was found to associate with elevated inflammatory cytokine and transcription 
factor compared to insulin sensitive metabolically healthy obese (39). Macrophage production 
of proinflammatory mediators also plays a role in the pathogenesis of non-alcoholic fatty liver 
disease (40). Activation of Kupffer cells, specialized macrophages found in the liver, to a 
proinflammatory state may cause hepatocyte damage and natural killer cell deficiency to 
promote steatosis (41, 42). 
Chronic low-grade inflammation may be modulated, in part, through dietary patterns 
(43). Generally, high fat, meat-based Western-type diets may promote low-grade inflammation 
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whereas plant-based diets inclusive of fruit and vegetables are associated with reduced 
incidence of inflammation (44). The postprandial period is a potentially important window in 
which diet may modulate low-grade inflammation (2, 45, 46). Although the postprandial period 
has been defined to extend 8 hours following the ingestion of a meal, diet-induced changes in 
endothelial function may occur much sooner after a meal (47, 48). Further to this point, the 
transient elevation in proinflammatory mediators during the postprandial window after a fatty 
meal has been proposed as a causal factor in vascular disease (49). Considering eating may 
occur multiple times throughout a single day, postprandial inflammation has been suggested to 
increase risk cardiovascular disease and cardiac events (50, 51). The type of food in a meal also 
elicits different postprandial inflammatory effects. 
Meals containing carbohydrates raise blood glucose that subsequently removed from 
the bloodstream by insulin. In diabetics, however, hyperglycemia may occur that causes an 
inflammatory response through oxidative stress (52). Postprandial hyperglycemia has been 
suggested to inhibit quenching of inflammation through the reduction of antioxidants (53). 
However, conflicting evidence exists as to whether hyperglycemic-induced pro-oxidative effect 
or reduction in the antioxidant capacity occurs in non-diabetic, healthy adults (54, 55). Although 
postprandial glycaemia has been variously associated with increased risk of CVD and other 
chronic disease, a consensus has not been reached as to under what condition(s) and in which 
population(s) might postprandial glycaemia modulate these health outcomes (56). 
Dietary fat intake, low-grade inflammation, and health 
 Western dietary guidelines promote the consumption of polyunsaturated and 
monounsaturated fats but advise a limited intake of saturated fat (57).  Total fat intake per day 
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is recommended to represent 35% or less of total calories consumed. However, less than 10% 
of calories per day is recommended to come from saturated fat. Attention has also been given 
to the intake ratio of polyunsaturated fatty acids (PUFA). The Western diet is typically deficient 
in n3 but not n6 PUFA, leading to a high n6:n3 ratio (58). Although high dietary fat intake 
remains proscribed, dietary fatty acid composition has been ascribed potential importance in 
the development of chronic disease (59, 60). 
High fat diets are associated with chronic inflammation and have been linked to the 
onset of several contributing factors to metabolic syndrome, including obesity and insulin 
resistance (61-63). A diverse set of chronic inflammatory diseases linked to high fat diets 
include cardiovascular disease (CVD), cognitive decline, and steatohepatitis (64-66). Recently, 
high dietary fat intake has been suggested to facilitate a heightened risk of developing CVD and 
several conditions of metabolic syndrome through increased intestinal absorption of bacterial 
lipopolysaccharide (LPS) (2, 63). However, circulating subclinical concentrations of LPS have a 
yet undefined role in generating chronic, low grade inflammation (67, 68).  Moreover, it is 
unclear what role low-fat diets may play in reducing endotoxemia and whether this is important 
in reducing disease risk since conflicting evidence exists for low-fat diets as protective against 
CVD (69, 70). 
  Distinctions are also made regarding the type of fat in affecting endotoxemia that might 
mediate a reduced or increased chronic disease risk (59, 69).  While saturated fat intake has 
been associated with CVD and mortality, only recently has dietary saturated fat been shown to 
increase intestinal absorption of LPS (71, 72). Although n6 PUFA have been reported as pro-
inflammatory, whether this effect is mediated via endotoxemia is currently unclear as dietary 
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n6 PUFA were separately demonstrated to decrease and increase both endotoxemia and 
inflammatory biomarkers (73-76). Likewise, whereas intake of n3 PUFA decreased risk of CVD 
and cognitive decline, if this benefit is causatively-linked with separate findings of n3 PUFA as 
protective against LPS-induced inflammation and LPS uptake across the gut, is an ongoing area 
of research (3, 77-79). As such, the ratio of n6:n3 may continue  to play an important role in the 
nutritional prevention of some degenerative diseases (58).  However, the notion that saturated 
fat or n6 PUFA are strictly pro-inflammatory and associated with increased risk of CVD has been 
overturned (80, 81). Although, several potential mechanisms exist for the divergent actions of 
saturated fatty acids and n6 or n3 PUFA affecting inflammation and health, endotoxemia may 
be a predisposing factor to several chronic diseases modulated by the type and quantity of 
dietary fat intake (5, 63, 82, 83). 
What are LPS and endotoxin? 
 LPS 
Generally, LPS is described to be a molecule composed of outer, middle, and inner 
regions, all or some of which may contain various substituents, including phosphate groups (1). 
The outermost region, termed the O-antigen or O-polysaccharide, is a hydrophilic carbohydrate 
polymer. The middle region, commonly referred to as a core region, is an oligosaccharide that 
may be further divided into inner and outer sections. The inner region, called lipid A, is 
hydrophobic and composed of multiple esterified or amide-linked fatty acids.  
LPS variations occur widely among bacteria that can modify their own LPS structures (1). 
Certain environmental signals or stressors, such as internal pH of a macrophage or host 
recognition of the bacterium, can stimulate bacteria to modify LPS (84, 85). As Salmonella 
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typhimurium and typhi invade epithelial, dendritic, and M cells along the intestinal epithelium, 
endocytosed Salmonella spp. must survive the intracellular environment (86).  
This would suggest that within the human gastrointestinal tract in vivo exists a spectrum 
of LPS structures (87, 88). The use of a purified LPS denotes high specificity of LPS structure. 
Purchase of LPS is typically from a single organism and strain (e.g. E.coli O55:B5) (89). 
Depending on the type of extraction procedure used, the LPS structure isolated, will vary (90). 
As such, chemically purified LPS represents a form of the molecule that is distinct from LPS 
found in vivo (91). Because it is well-recognized that the structure of LPS is intimately involved 
in immune recognition and initiation of an immune response, host inflammatory reaction(s) 
and mechanistic pathway(s) to a chemically purified LPS may be distinct from an LPS shaped 
from in vivo conditions (1) (92). 
Endotoxin 
Endotoxin does not have a singular definition and the terms endotoxin and LPS are used 
interchangeably to describe the same whole LPS molecule  The term, endotoxemia does not 
allow distinction of endotoxin from LPS, as there is no other term to describe LPS or endotoxin 
in the bloodstream; investigators who have intravenously delivered purified LPS to human 
subjects, call the subsequent condition, endotoxemia (93). Intravenous administration of 
purified LPS into people, termed human endotoxemia, is used as a model to study systemic 
low-grade inflammation (93). When bolus and continuous infusions of LPS are used, however, 
the magnitude of inflammatory response, differs depending on the mode of delivery choice 
(94). This model has been used in assessing anti-inflammatory effects of PUFA supplementation 
in humans (95, 96). However, the intravenous delivery of LPS represents no known disease or 
15 
 
infection thereby making the extrapolation of such findings to any other scenario that does not 
involve intravenous LPS administration, likely inappropriate. Several other considerations that 
are highlighted later in this review, include the use of purified or native LPS, use of LPS from a 
single bacterial species, and the unresolved question of whether at all LPS is present in the 
bloodstream, caution the relevance of this model to dietary fat-induced postprandial 
endotoxemia and inflammation.   
Why are dietary fatty acids relevant to LPS?  
Structural homology to lipid A  
 The lipid A portion of LPS contains multiple fatty acids that are commonly found in food 
(97, 98).  Because the lipid A region is regarded as the primary inflammatory component of LPS, 
there is concern that  dietary saturated fatty acids may activate microbial-associated molecular 
pattern (MAMP) receptors, such as TLR4, that respond to lipid A (99) (100, 101) (102). 
Stimulation of TLRs have been variously identified to play a role in the pathogenesis of chronic 
disease including atherosclerosis and type 1 diabetes (103). The lipid A region contains medium 
and long chain saturated and, less frequently, monounsaturated fatty acids (1). 
Polyunsaturated fatty acids, such as docosahexaenoic acid, have not been found to naturally 
occur in any lipid A studied to date.   
Lipid A is not composed of a single type of fatty acid but is often heterogeneous in its 
make-up, including lauric (C12:0), myristic (C14:0), palmitic (C16:0), hexadecenoic (C16:1), 
and/or other fatty acids. Saturated fatty acids are common constituents of lipid A and typically 
include C12:0 or C14:0. Longer saturated fatty acids not limited to C16:0 and stearic acid 
(C18:0) have been identified in lipid A structures (104) (105).  Lauric, myristic, and other 
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saturated fatty acids have been reported to elicit macrophage and adipocyte TLR4 activation in 
absence of LPS challenge (100) (106, 107). However, separate findings have reported the 
inflammatory effect of saturated fatty acids was instead due to LPS or bacterial lipoprotein 
contamination of reagents and fatty acids (102). Whether systemic low-grade inflammation 
occurs from the regular consumption of diets rich in saturated fat is unclear since the pro-
inflammatory effect of dietary saturated fat consumption may instead depend on the type of 
saturated fat and be modified by other components of a meal (108) (109). 
 Monounsaturated fatty acids are infrequent constituents of lipid A, which may play a 
role in increasing membrane fluidity in cold environments (1, 110) (111, 112). 
Monounsaturated fatty acids that have been identified in lipid A include palmitoleic and 
octadecenoic (C18:1) acids (113, 114) (115, 116). The presence of monounsaturated fatty acids 
has been reported to reduce bacterial immunogenicity. For example, the removal of palmitoleic 
fatty acid from Yersinia pestis lipid A, which is overwhelmingly composed of saturated fatty 
acids, accompanies an increased immunogenicity (114, 117, 118). 
Dietary n3 PUFA have long been identified to mitigate or prevent LPS-induced 
inflammation, fever, and mortality in vitro and in vivo (79, 119-121).  Suggested daily intakes of 
n3 PUFA from a variety of food sources, including seafood, may provide a nutritional avenue by 
which to address LPS-associated inflammation (122, 123). However, advisory body 
recommendations for daily intake vary widely (124). For example, for adult men and women, 
the European Food Safety Authority recommends 250mg/day while the American Heart 
Association suggest 1000mg/day or 2 servings of fatty fish per week (125). Recent population 
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data indicate American adults are below both recommended levels for fish intake and exhibit 
low plasma concentrations of n3 fatty acids (126, 127). 
 Hitchhiking in chylomicrons  
 Increased fatty acid absorption has been shown to occur during high dietary fat intake 
(128). Fatty acid absorption and intracellular repackaging via the enterocyte provides a 
potential route by which LPS may enter systemic circulation (129). LPS may be internalized by 
the epithelial cell to TLR4 located in the Golgi apparatus (130).  Within the enterocyte, fatty 
acids are re-esterified as triglycerides (131). Because synthesis of triglycerides, along with other 
components, into chylomicrons continues from the endoplasmic reticulum into the Golgi 
apparatus, the latter organelle provides a common meeting ground where LPS, too, may be 
packaged into chylomicrons.  
 Chylomicrons are basolaterally secreted into the lymphatic system (131). Because the 
lymph bypasses the portal vein and instead feeds into systemic circulation, LPS packed-
chylomicrons gain access to the endothelium. Since endothelial cells are well-recognized to 
contain MAMP receptors, including TLR4, systemic exposure to LPS has been implicated as a 
predisposing factor for multiple inflammatory diseases, including atherosclerosis (132, 133). 
Exposure of the endothelium to LPS is theorized to occur with the distribution of chylomicron 
contents (129). A single high fat meal has been suggested to be atherogenic in healthy adults 
(48). Whether a negative effect on endothelial function is related to dietary fat-induced change 
in blood endotoxin concentration is unclear as endotoxemia has been associated with total 
energy intake but not fat intake in healthy men (134). Although it was reported that a high fat 
meal fed to healthy adults induced postprandial endotoxemia with no change in blood 
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inflammatory markers, a separate investigation found a high fat meal to induce postprandial 
inflammation with no change in blood endotoxin concentration (68, 135). 
 Modulation of intestinal epithelial cell membrane fluidity 
The plasma membrane lipid composition of intestinal enterocytes, to some degree, 
reflects the type of fatty acids consumed in the diet in vivo (136, 137).  Supplemental fatty acids 
in cell culture growth media have been shown to be incorporated into the cellular plasma 
membrane in a variety of cell types (138, 139). Because MAMP receptors responsive to LPS, 
including TLR4, are found in the membrane of enterocytes and colonocytes, membrane fluidity 
alterations via incorporation of saturated and unsaturated fatty acids may increase and 
decrease receptor availability to extracellular content, including LPS (140-142).  
Enterocyte membrane lipids have received attention in light of the lipid raft hypothesis 
(143-145).  The lipid and protein heterogeneity of the phospholipid bilayer is thought to be 
distributed to meet the unique demands of the extra- and intra-cellular environments (146). 
The extracellular-face of the phospholipid bilayer may be further organized into microdomains 
called lipid rafts. These microdomains are theorized to be composed of cholesterol, 
sphingolipids, and saturated fatty acids (147). Excluded from these rafts are unsaturated fatty 
acids (147). Proteins are suggested to have affinity for lipid raft or non-lipid raft regions; the 
receptor TLR4 is thought to localize to lipid rafts (140).  The proportions of cholesterol, 
sphingolipids, saturated, and unsaturated fatty acids can be modulated through diet (148). 
Hence, because the exoplasmic face of the enterocyte membrane functions in both nutrient 
absorption and the exclusion of microorganisms, dietary fatty acid composition may play a 
modulatory role in the ligand-independent activation of TLR4, as well as the potential 
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stabilization of lipid raft localized TLR4 for enterocyte uptake of LPS, and thereby initiate or 
mitigate inflammation (140).  
Polyunsaturated fatty acids do not change abundance of TLR4 within the plasma 
membrane, but instead prevent dimerization of TLR4 even if LPS has bound to cell-membrane 
TLR4 (140, 149).  This is critical to the concept of LPS uptake from the gut lumen and 
subsequent endotoxemia as saturated fatty acids may induce inflammation through activation 
of TLR4 but not enhance LPS binding to the apical membrane of the intestinal epithelial cell. 
Endocytosis of the TLR4 complex with bound LPS occurs upon TLR4 dimerization (150). Since 
PUFA does not block LPS apical membrane binding, but instead presumably prevents 
dimerization of TLR4 even in the presence of LPS, endocytosis of TLR4 and thus cellular uptake 
of LPS, may be prevented.  
LPS absorption across the small intestine epithelium has been demonstrated to be 
increased from feeding of saturated fat but decreased following either n3 polyunsaturated fat 
feeding or disruption of lipid rafts (3). A beneficial role has been ascribed to dietary n3 PUFA in 
ameliorating chronic inflammation in the small intestinal epithelium in vivo (151). Moreover, 
while several studies have reported supplementary n3 PUFA to improve intestinal function in 
individuals suffering from inflammatory bowel disease, a clear role in the large intestine has not 
yet been established (152). 
PUFA anti-inflammatory effect and TLR4 
Polyunsaturated fatty acids may also repress the LPS-induced TLR4 signaling cascade via 
action at sites independent of the TLR4 receptor itself. TLR4 initiates multiple transcription 
factors, including NF-kB and AP-1 (153). Since these transcription factors directly lead to the 
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production of chemotactic and proinflammatory cytokines, regulation of cellular tight junctions 
in the gut epithelium, and hence permeability to luminal LPS, is of potential concern (154, 155). 
Both n3 and n6 PUFA has been separately shown to prevent translocation of NF-kB or AP-1 
from cytoplasm to the nucleus in response to LPS stimulation (156) (157). Additionally, n3 and 
n6 fatty acids have been demonstrated to repress pro-inflammatory transcription factor 
translocation via binding to a G-protein coupled receptor (GPR)-120 (158).  
Distinguishing native and purified LPS matters in LPS uptake and immune response  
Eukaryotic and prokaryotic biological mechanisms have evolved to negotiate LPS as 
native LPS, that is, as part of the bacterial outer membrane. The purification of LPS for use in 
experimental investigation, not only may alter, but often bypasses numerous biological 
pathways that feed into, and often regulate, response to LPS. 
 Environment as signal: Bacteria modulate LPS immunogenicity  
An initial step of Shigella spp., a Gram-negative microorganism, pathogenesis is 
replication within intestinal epithelial cells (159). Host intracellular response to Shigella spp. 
infection involves the recognition of the lipid A via a TLR-dependent mechanism. Because the 
lipid A portion is buried within the bacterial outer membrane, host lipopolysaccharide-binding 
protein (LBP) is required for the extraction of LPS, and subsequent presentation of LPS to the 
initial receptors involved in the TLR signaling cascade (160). Although inside the epithelial cell, 
Shigella spp. actively produces hypo-inflammatory penta- or tetra-acylated lipid A, small 
amounts of inflammatory hexa-acylated LPS are produced (161). Since LBP does not 
preferentially bind hexa-acylated over hypoacylated forms of LPS, that LBP is essential for the 
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rapid response to infection indicates LPS location within the endotoxin complex is itself a 
biological hurdle to immune response (162, 163).  
The Gram-negative outer membrane sequesters lipid A 
Hydrophobicity of immunostimulatory molecules has been argued to play an 
evolutionary role in microorganism survival (164). Initial stages of the pathogenesis of some 
Gram-negative organisms, including Shigella spp. and Salmonella spp., may evade immune 
recognition through lipid A modification, thereby suggesting despite lipid A being sequestered 
within the membrane, hydrophobicity does not prevent host recognition (165). However, it 
should be recognized that the need for lipid A remodeling is necessitated by host LPS sensing 
mechanisms that rely upon LPS extraction proteins, such as LBP. In the classical LPS signaling 
pathway involving soluble cluster of differentiation (sCD)-14, myeloid-differentiation factor 
(MD)-2, and TLR4, LBP is not required for sCD14 to bind purified LPS (166). Conversely, in order 
to bind LPS located in bacterial outer membrane fragments, sCD14 appears to require LBP to 
extract and transfer LPS to the sCD14 binding site (167). Hydrophobicity, or at least the 
sequestering of immunogenic lipid A to the interior of a membrane may then be argued to play 
a role in preventing host sensing of LPS. 
Micelle or proteoliposome? 
In aqueous environments, such as blood or the gut lumen, purified LPS will form large 
micellar aggregates (168). Conversely, native LPS in bacterial fragments or outer membrane 
vesicles may form large heterogeneous proteoliposomes that contain flagellin, proteins, non-
LPS lipids, and other bacterial membrane components (169).  Large micellar LPS aggregates are 
internalized differently than is monomeric LPS (170) (171). LPS in outer membrane fragments, 
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however, is released by LBP and transferred to sCD14 to form a monomeric LPS-sCD14 complex 
(167, 172). Because internalization of aggregated LPS occurs quicker than does monomeric LPS, 
and membrane-bound (mCD14) has been shown to internalize with aggregate LPS but not 
monomeric LPS, unique pathways of LPS uptake may depend on the presentation of LPS in the 
environment (170, 173).  
LPS purification alters host immune response 
The heterogeneous composition of endotoxin also has distinct implications in 
determining host immune response (174). Although C3H/HeJ mice are unresponsive to LPS 
challenge, live or heat-killed Gram negative bacteria does induce lethal septic shock (175). 
Components of the outer bacterial membrane, including lipoproteins, have been shown to act 
synergistically with LPS to elicit macrophage cytokine secretion (169, 176) (177). Purification of 
LPS from outer membrane fragments also attenuates magnitude of cytokine response (167, 
169). In vivo challenge using purified LPS may mislead investigations in the search for pro-
inflammatory mechanism(s) of bacterial pathogenesis (178, 179).  As such, study of complex in 
vivo mechanisms such as dietary fat-mediated gut absorption of LPS and systemic LPS-
associated inflammation necessitates distinction between native and purified LPS.  
LPS uptake from the gut: A role for dietary fat? 
From a translational perspective, it would be of interest to understand how native LPS 
might be transported across the gut epithelium. Purified LPS and, to a lesser extent, whole 
bacteria, have been used to evaluate aspects of intestinal permeability. Further to this point, 
translocation of live bacteria across the intestinal epithelium is inconsistently associated with 
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appearance of LPS in the blood—cautioning relevance of bacterial translocation as causative or 
predictive of endotoxemia (180). 
Very little evidence has directly evaluated the effect of dietary fatty acids on LPS 
transport across the intestinal epithelium. If intestinal barrier integrity is modulated through 
fatty acid alteration of tight junctions to enable a paracellular pathway of LPS absorption, 
epithelial paracellular permeability to LPS should be observed ex vivo. Although pig ileum 
sections treated ex vivo with different dietary oils were observed to transport luminal LPS 
(E.coli O55:B5) across the epithelium, perturbations in paracellular permeability were not 
observed (3). The authors concluded fatty acids modulate enterocyte transport of LPS via a 
transcellular and not paracellular route. In healthy rats, systemic dissemination of LPS was 
evaluated based on enteral-administration or intravenous injection of purified LPS (E. coli 
O111:B4; S. typhimurium) (181). Intravenous LPS was found in the intestinal lamina propria as 
soon as 1 hour and even after 28 days, following injection. Conversely, enteral-given LPS was, at 
all time points, only found in the lumen of the intestine without penetration into mucosa or 
appearance within enterocytes. Likewise, neither in intestinal tissues from sham-shocked or 
shocked rats, was LPS (E. coli O127:B8) observed to cross the mucosal face in Ussing chamber 
experiments (182). However, in the same experiments live E.coli was observed to transit to a 
lesser and greater extent in sham and shocked animals, respectively. The authors suggested 
that endotoxemia following shock may be the result of lysing or replication of bacteria that 
translocated, and not due to direct passage of LPS from the gut lumen. Alternatively, rabbits 
were first gavaged with LPS (E. coli O111:B4), and then 3 hours following gavage, subjected to 
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hemorrhagic shock or sham (183). Whereas in blood samples from shocked animals LPS was 
found, in sham-shocked animals LPS was not found.  
Gavage of mice with purified LPS (E.coli O111:B4) and triolein or tributyrin was observed 
in vivo to result in plasma appearance of LPS (129). The authors suggested a route of 
chylomicron formation, and hence transcellular pathway, by which dietary fatty acids increase 
gut luminal uptake of LPS. In an earlier study by a separate group, both purified lipoteichoic 
acid from Gram positive and LPS (E. coli O55:B5) from Gram negative bacteria were both found 
to be sequestered in chylomicrons in vitro (184). The proposed pathway of LPS incorporation 
into chylomicrons is partly based on evidence that LPS is trafficked to the TLR4 that is located in 
the Golgi apparatus (129, 130). Although a small intestinal murine epithelial cell line was used 
in LPS (E. coli O55:B5) internalization and Golgi trafficking experiments, the cells were not 
polarized (130).  
The role of emulsification in facilitating LPS uptake at the gut epithelium via 
chylomicrons has been examined in vivo both in humans and rats (185). In healthy adult men 
fed a high fat meal containing emulsified lipids, LPS was observed in chylomicrons separated 
from postprandial blood samples. It is critical to note that the authors did not feed purified LPS 
to the human subjects. As such it was concluded that the LPS in the chylomicrons was 
endogenous LPS taken up from what was already present in the gut. However, the authors did 
not include a human control group in the study. Moreover, while anti-LPS antibodies are well-
known to be contaminated with LPS, the authors did not report their anti-LPS antibody was 
tested for LPS  contamination (186). Nor was the high fat meal with emulsified lipids assayed for 
LPS content making it difficult to assess whether the native LPS was exogenous or endogenous. 
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In the same study as above, the authors assessed postprandial endotoxemia in rats 
following gavage of saline, oil + saline, or oil + emulsifier (185). It was found that postprandial 
blood endotoxin concentrations were significantly increased in the oil + emulsifier group, but 
saline was not significantly different from oil +saline. However, dietary lipids undergo 
emulsification via host bile salts. Why a pre-emulsified oil and not the same non-emulsified oil 
would exert differences in postprandial endotoxemia via potential LPS uptake from the gut 
lumen is uncertain. Separate studies have investigated the effect of fat droplet size in different 
emulsions on lipid absorption in the human small intestine (187). Although larger fat droplets 
undergo greater emulsification by endogenous bile salts compared to finer droplets, lipid 
absorption was not different between larger or smaller fat droplet sizes of the emulsions (187). 
Moreover, evidence does also point to the contrary wherein high or very high fat diets reduce 
endotoxemia (188) (189). 
 Although the chylomicron transcellular pathway of LPS absorption might be common to 
both purified and native forms of LPS, whether one form is transported more efficiently is 
unknown thereby making comparisons of endotoxemia following orally-fed purified LPS or 
meals with detectable native LPS, difficult. A distinction between purified and native forms of 
LPS is that the former forms large micellar aggregates in aqueous environments (168). Likewise, 
as purified LPS aggregate, whether digestive emulsification further increases the surface area of 
purified LPS micelles enabling increased uptake, via TLR4 pathway or otherwise, is unknown. 
Native LPS may be present in some food sources but how completely it is absorbed in a 
meal approach is unknown (190). For example, healthy adult participants’ who consumed an 
orange juice drink which totaled 55250 EU, did not observe baseline endotoxin concentration of 
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0.15 – 0.35 EU/mL to increase more than 200% at 0, 1, 3, or 5 hours postprandial (191). Healthy 
adult men who consumed a meal with 50g butter containing ~1750EU saw an average 
postprandial rise of <0.01 EU/mL in blood endotoxin (2).  
The effect of dietary fatty acid composition has received limited attention in affecting 
postprandial endotoxemia and inflammation. In mice fed diets that differed in percent 
saturated, monounsaturated, or polyunsaturated fatty acids for 8 weeks, the saturated fat diet 
(palm oil) resulted in the lowest blood endotoxin whereas monounsaturated fat diet (rapeseed 
oil) effected the highest endotoxin concentration (74). However, how fatty-acid mediated 
alterations in blood endotoxin affect inflammation is unclear as lipopolysaccharide binding 
protein (LBP) and IL-6 were highest in the palm oil-fed mice, while IL-6 was lowest in the 
rapeseed oil group. Whether LBP is a representative measure of endotoxemia-associated 
inflammation is uncertain as LBP is nonspecifically secreted in response to multiple 
inflammatory stimuli as it also acts against Gram-positive bacteria (192, 193). Likewise, IL-6 is 
also secreted as a proinflammatory cytokine to many MAMP, not only to LPS (194).  
Unlike in mice, pigs fed a single meal differing in dietary fatty acid composition exhibited 
greatest and lowest blood endotoxin concentrations following ingestion of a saturated fat-rich 
meal (coconut oil) and polyunsaturated fat-rich (fish oil) meal, respectively (3).  Although 
postprandial endotoxin was measured, the authors did not assess inflammation. In overweight 
and obese men, lower postprandial endotoxemia was observed following consumption of high-
oleic acid or conventional peanuts compared to a control meal that did not contain peanuts 
(73). Likewise, how this change in endotoxemia was associated with inflammation is not known 
as inflammation was not studied.  
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Mice (male C57BL/6J) fed an extremely high fat diet (72% fat, <1% carbohydrate energy 
content) for 4 weeks did not significantly differ in blood endotoxin concentration from control-
fed mice continuously subcutaneously infused with LPS (E.coli O55:B5; 300µg/kg 
bodyweight/day) for 4 weeks (63). These results contrast with separate findings in which a very 
high fat diet reduced murine (male C57BL/6J) blood endotoxin (189). Although fat-fed mice 
daily energy intake was significantly greater than LPS-infused control fed mice, the different 
diets used in the study were not assayed for LPS content (63). As such, the source of LPS in fat-
fed mice—whether from the gut microbiota, or from the diet—is unclear. Importantly, mRNA 
expression of several inflammatory cytokines, and some changes in liver markers exhibited 
relative similarity between the fat-fed and LPS-infused control fed mice. In a separate set of 
experiments in the same paper, the authors used CD14-deficient mice and found that in the fat-
fed as well as in LPS-infused control-fed mice, inflammation and obesity were both prevented. 
Therefore due to the similar blood endotoxin concentration, the metabolic dysregulation, 
bodyweight gain, and increase in inflammation in both the fat-fed and LPS-infused control fed 
groups were argued to be mediated via LPS activity at the CD14 receptor. This conclusion 
challenges the role of saturated fatty acids modulating the TLR4 receptor in a ligand-
independent fashion, as absence of CD14 should not prevent ligand-independent dimerization 
of TLR4 (195). However, in a separate report, the same extreme high fat diet fed ad libitum to 
the same mice strain was only seen to produce an obese phenotype in 2.1%, 24.8%, and 47.2% 
of the mice at 3, 6, and 9 month time-points (196).  
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Intestinal microbiota as an endogenous source of LPS absorbed from the gut lumen 
The gut microbiota have been implicated as a source of endogenous LPS that is 
transported into systemic circulation in individuals fed high fat diets (63, 197).  Conversely, 
under conditions of hemorrhagic shock, enteral administration of high fat diets have been 
found protective against LPS translocation from the gut (188). Although very high fat diets have 
marked effects on the murine small intestine, evidence in support of high fat diet-induced 
endogenous LPS translocation is largely correlative and derived from the site of the murine 
cecum (198). For example, while very high fat diet fed to mice reduced cecal Gram-negative 
taxa, it also reduced certain cecal Gram-positive groups, including Bifidobacterium spp. (63, 
199). A later study found that protection afforded from fermentable prebiotic administration to 
mice against very high fat-diet increase in blood endotoxin concentration was positively 
correlated with higher cecal content of Bifidobacterium spp. (200). However, a separate report 
suggested dietary fatty acid-induced fluctuations in blood endotoxin in mice are not positively 
correlated with a higher cecal presence of Gram-negative organisms (74). 
It is difficult to predict gut-derived endotoxemia from specific changes in gut microbiota 
from distinct gut regions when evidence for such changes is derived from different animal 
species (201-203). For example, while humans have a cecum that does not have a clear 
function, mice and pigs contain functional ceca (141, 204). Moreover, Bifidobacterium spp., 
which are present in the human and murine gut and exert anti-inflammatory action and 
preserve cellular tight junction integrity against LPS challenge in intestinal epithelial cells, has 
been reported as undetectable in the porcine intestinal tract (199, 204, 205).  
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Several common taxonomical groups have been identified in different regions of the 
intestinal tracts of the mouse, human, and pig. However, among mice, humans, and pigs, 
inconsistent changes in relative abundances of dominant Gram-positive and negative phyla 
such as Firmicutes and Bacteroidetes occur following dietary interventions and also depend on 
body phenotype, such as obesity (203, 204). Genus level taxa such as Lactobacillus spp. have 
been shown more abundant in the mouse and pig than in the human gut. Conversely, certain 
strains of Lactobacillus have been shown to reduce intestinal inflammation induced by oral 
gavage of LPS (206). Indeed, the common presence of bacterial species in murine and human 
intestinal tracts does not imply common function and interaction with the host (203, 207).   
Regional diversity of the microbiota occurs along the murine gastrointestinal tract (208).  
Moreover, regional functionality of the intestinal tract has shown the small intestine is 
principally involved in dietary fat absorption and the cecum in fermenting plant material (203, 
209). The murine small intestine has been shown to adapt, including increase in villi surface 
area, to chronically high fat diets (128, 198). The major conceptual problem of the theory of the 
gut microbiota as the endogenous source of LPS absorbed under high fat diet conditions, is that 
the use of a prebiotic leads to fermentation by bacteria in the cecum, but the dietary fat would 
be assumed to be almost totally absorbed in the small intestine. Unfortunately, the authors 
who assessed Bifidobacterium spp. in the murine gut did not evaluate appearance of fat in the 
cecum, large intestine, or feces, and therefore it is uncertain if fat escaped the small intestine 
to act within the cecum or large intestine. Evidence from the appearance of LPS in chylomicrons 
in vivo also suggests, if LPS uptake occurs, it does so in the small intestine. Moreover, how 
Bifidobacterium spp. contributes to a reduction in blood LPS concentration, either through 
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reducing the amount of LPS in region(s) of the gut, exerting an anti-inflammatory effect on the 
epithelium, improving intestinal epithelial tight junctions, or a combination of factors is 
unknown in high fat diet-induced endotoxemia (199, 210, 211).  
Although the intestinal tract contains regional differences in microbial populations, 
coprophagy may expose upper regions of the intestinal tract to Gram-negative organisms and 
endotoxin of the bowel (212). Hence, comparison of studies in which dietary regimes, for 
example, fatty acid composition or high fat diets, are evaluated as modulatory of LPS 
absorption from the gut should consider whether studies being compared used a non-
coprophagic and a coprophagic species (213, 214). Additionally, whether the investigators 
prevented, permitted, or did not control for coprophagy as a confounding effect is an important 
consideration overlooked in some relevant studies (197, 215).  
 Additional evidence implicating the gut microbiota as the endogenous source of LPS 
taken up under high fat diet conditions is from the use of antibiotics in mice (197).  Mice were 
fed an extremely high fat diet (72% fat, <1% energy from carbohydrate) with or without the 
antibiotics ampicillin and neomycin added in drinking water for 4 weeks. The blood endotoxin 
concentration of antibiotic treated fat fed mice was significantly lower than fat-fed mice that 
did not receive antibiotics, and was not different than control fed mice. Because antibiotic-
administration reduced several inflammatory transcript markers that were increased by fat rich 
diet alone, the authors determined fluctuations in cecal microbiota were causative of 
inflammation.  Since LPS was not fed to the mice, and reduction in bacteria via antibiotics was 
also associated with a reduction in blood endotoxin concentration, the authors concluded that 
the LPS was derived from the cecal microbiota.  
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There are several potential problems with this conclusion, however. First, the LPS 
content of the diets were not measured by the investigators. As such, whether LPS absorbed 
from the gut is exogenous or from endogenous microbiota remains an open question. Second, 
neomycin can be used to cause malabsorption of dietary fats from the gut lumen in the 
treatment of hyperlipidemic patients (216).  Neomycin disrupts intraluminal micelle formation 
in the gut, leading to small intestine malabsorption of ingested fats and, possibly, steatorrhea 
(217). If the neomycin given to mice under extremely high fat diets did cause fat malabsorption, 
it would be reasonable to look for increased cecal content of lipids in the antibiotic treated 
group. In fact, the authors did note the fat-fed group treated with antibiotics had 6-fold greater 
cecal lipid content compared to fat-fed group without antibiotics. This effect was also seen in 
control fed mice with and without antibiotics (197). Moreover, the antibiotic-treated fat-fed 
group exhibited increased energy intake and decreased bodyweight relative to the non-
antibiotic treated fat fed group. However, the implications of these effects in explaining a 
microbiota-independent effect on reduction of blood endotoxin was not mentioned by the 
authors. Since dietary fat is absorbed in the small intestine, and chylomicron uptake of LPS from 
the gut occurs in the small intestine, it may be that the antibiotic treatment of the mice simply 
reduced the amount of lipids absorbed, and hence less chylomicron formation in the small 
intestine. 
Translational considerations in the intersection of dietary fat, LPS, and inflammation 
 The immune systems of humans and other animals such as mice and pigs are generally 
similar but do contain distinctions important to the intersection of inflammation, dietary fatty 
acids, and LPS (107, 218, 219). Species-specific modifications to TLR4, MD2, and other receptors 
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determine pro- or anti-inflammatory response to lipid A (220). Despite evidence for dietary 
fatty acids as ligands for TLR4, species-specific variation in these receptors has not received 
attention for distinct response to fatty acids (140). Differences in recent reports in mice and 
swine of postprandial endotoxemia following a monounsaturated oil-rich diet or a saturated 
fat-rich diet, suggests classes of fatty acids may evoke distinct responses at the intestinal 
epithelium in different species (3, 74). Variation of structural diversity and patterns of 
distribution of TLR4 as well as MD-2 among tissues of different species is implicated in aspects 
of species-specific immune response to LPS challenge (221). Strikingly, certain bacterial LPS are 
agonist and antagonist to equine and human TLR4/MD2, respectively (222). The cytokine, 
interleukin (IL)-8, is a leukocyte chemoattractant produced by LPS stimulation of TLR4 and 
during endotoxemia (223). Humans and swine produce IL-8 whereas mice completely lack a 
gene for IL-8 (224). Differences in LPS sensitivity among species may be extreme; a reference 
range of 1-25mg/kg bodyweight as the LD50 of intravenous LPS in wild-type mice has been 
estimated as 1000 to 10000-fold greater than in humans (225).  
 Gut biogeography  
 MAMP receptors, including TLR4 are found at multiple sites along the epithelium of the 
intestinal tract (226-228).  As the canonical inflammatory pathway of LPS, TLR4 is widely 
implicated in both potential paracellular and transcellular intestinal luminal uptake of LPS and 
fatty acid-mediated inflammation (100, 130, 153, 154). Since food may contain in addition to 
endotoxin a wide range of TLR-stimulatory compounds, the luminal presentation and 
distribution of TLR4 varies depending on tissue region (229-231).  
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The biogeography of the small and large intestines are distinct in multiple aspects 
important to LPS uptake and fatty acid modulation of TLR4. Penetration of mucosa and 
absorptive surface area are central considerations for epithelial absorption of bacteria and LPS. 
Briefly, the small intestine contains a single mucosal layer whereas the large intestine contains 
outer and inner mucosa (232). Enterocytes protrude farther into the lumen than do 
colonocytes, as the former is composed of villi and crypts and the latter only crypts (228, 233). 
The thickness of the mucosa is unique to both regions, and for example may exceed the height 
of the small intestinal villi (234). Unique depth gradients exist of bacterial penetration into the 
mucosa of different intestinal regions (235). Whereas enterocytes may express both apical, 
towards the lumen, and basolateral, away from the lumen, TLR4, enteroendocrine cells may 
only express TLR4 basolaterally (228).  
Paneth cells, which are epithelial cells that control bacterial invasion into the 
epithelium, secrete antimicrobial peptides through TLR-dependent sensing of microbes or 
microbial debris such as LPS, are found in the cecum, small intestine, and proximal colon of 
humans but only in the small intestine of mice (203, 236). It is currently an issue of debate 
whether the pig contains Paneth cells (237). The divisions between the duodenum, jejunum, 
and ileum sections are not as distinct in the pig as in the human; a continuous, sole Peyer’s 
patch may extend from the terminal jejunum through the ileum of the pig, while human ileum 
contains more numerous individual Peyer’s patches than the jejunum (238, 239) (240). Peyer’s 
patch contain several cell types involved in conferring mucosal immunity through the regular 
sampling of luminal antigens such as LPS (241). 
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Microbial colonization of the gut progresses in scale from the lumen of the small 
intestine, 102 CFU/g, through the large intestine, 1011 CFU/g (232). Antimicrobial and MAMP 
expression follows an inverse distribution to microbial density (232). The common estimate of 1 
gram of LPS in the gut is largely a comment upon the abundant microbiota of the colon (242). 
However, tightly regulated infiltration by bacteria of the outer and inner mucosa and reduced 
presence of MAMP receptors suggests a limited role, if at all, of the colon epithelium in both 
absorbing LPS and initiating an LPS-induced inflammatory response despite a rich microbial 
reservoir (243, 244).  
  Because the jejunum and ileum of the small intestine performs the majority of 
absorption of nutrients, including medium and long-chain dietary fatty acids, and contains a 
larger presence of MAMP receptors, it is necessarily the intestinal site of primary interest to LPS 
absorption and fatty acid-mediated inflammation. Moreover, circadian rhythm, through CLOCK 
gene regulation, modulates both enterocyte lipid absorption and expression of TLR4 and other 
MAMP receptors (245, 246). Circadian control may suggest dietary consumption patterns to 
play a determining role in whether consumption of a saturated fatty acid rich meal during the 
daytime or nighttime elicits different patterns of epithelial inflammation and LPS uptake.  
Fatty acid modulation of LPS inflammation  
Dietary fatty acids may elicit or mitigate LPS-induced inflammation in the intestinal 
epithelium, however, several considerations suggest caution to the extrapolation of in vitro 
outcomes to other cell lines and ex vivo or in vivo environments. Use of colonocytes as well as 
non-gut derived cell lines and purified LPS disregard the complexities of gut biogeography and 
native LPS. Studies in which colonic epithelial cells were incubated with medium and long chain 
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dietary fatty acids to modulate inflammation or LPS absorption presents an inverted in vivo 
scenario of colon and small intestine (129, 185, 247).  
Since intestinal epithelial cells are polarized and covered in mucosa, the direct 
application of purified LPS or fatty acids to intestinal epithelial cells represents a situation not 
encountered in vivo (232) (248). Bacterial products, dietary nutrients, and other molecules 
must pass through multiple layers in order to reach the epithelial cells. Hypo-responsiveness of 
healthy colonocytes to E.coli purified LPS, contrasts sharply with hyper-responsiveness of non-
gut derived macrophages in vitro to application of E.coli purified LPS (100, 249). Although 
macrophages of the intestinal epithelium express TLR4, they do not express co-receptors such 
as CD14 involved in TLR4 complex formation, have repressed NF-kB function, and do not 
secrete proinflammatory cytokines (250). Even though human THP-1, HEK-293, murine 
RAW264.7, and other non-intestinal epithelial cell lines are able reporters of LPS-TLR4 activity, 
how inflammatory response from incubation with fatty acids contrasts with polarized intestinal 
enterocytes which function in the absorption of exogenous nutrients, is not known.  
Endotoxemia, low-grade inflammation, and the LAL assay 
There is conflicting correlation between blood endotoxin concentration during the 
postprandial period and low-grade inflammation (2, 135, 185, 197). Blood endotoxin in humans 
and animals is often measured using the LAL assay. The numerous technical challenges with the 
LAL assay have been addressed at-length elsewhere (251, 252)—newer assays that may replace 
LAL are, too, recognized as problematic (253). The specific problem of the LAL assay of 
relevance in this review is the investigator’s interpretation of the assay’s results.  
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The purified LPS used to generate standard curves is typically E. coli O55:B5 or 
O111:B4—the growth conditions of which are not specified by the manufacturer. Therefore, 
the results of whatever strain of LPS is in the investigator’s sample is determined in EU/mL of 
the standard E. coli, not in EU/mL of the unknown strain of LPS in the sample. This is further 
contextualized in the reactivity of LAL substrate against the E. coli LPS used in the standard 
curve. For example, whereas LAL substrate reactivity against Bordetella pertussis LPS was 
greater than response to the E. coli standard endotoxin, the inverse reactivity was found in 
human monocytes (254). Extraction and purification procedure of LPS from the same bacterial 
species also impacts reactivity in the LAL assay (255).  
Although there is different reactivity by the LAL substrate against different LPS, the LAL 
substrate reacts against all types of lipid A but mammalian immune systems do not react to all 
forms of lipid A (91, 221, 256). Human platelets distinguish between different types of LPS and, 
depending on the type of LPS, secrete different types and concentrations of cytokines (257). 
The distinction between immunostimulatory and non-immunostimulatory native LPS in the gut 
lumen has recently been proposed to play a critical role in the prevention of certain 
autoimmune diseases (258, 259). Measures of blood endotoxin may indeed register as a certain 
endotoxin concentration in the LAL assay but whether or not the LPS in the sample is highly, 
mildly, or not at all immunostimulatory to the host from which the sample was taken, is 
unknown. Therefore, the presence of endotoxin in a blood sample may spark ideas of 
inflammation without questioning whether or not the LPS in the sample elicits host species-
specific inflammatory response.   
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 The hurdle of translating LAL detection of LPS to physiological inflammation may help to 
explain the unclear relationship between dietary fat, inflammation, and endotoxemia. In 
healthy men, blood endotoxin was significantly elevated following consumption of a high fat 
meal as determined by the LAL assay, measures of inflammation such as C-reactive protein did 
not significantly increase and TNF-α was below the assay level of detection (2). However, the 
authors then incubated human aortic endothelial cells or monocytes with purified LPS (E. coli 
O111; the same LPS used to generate the standard curve of the LAL assay by the authors), and 
observed secretion of TNF-α and IL-8. Although serum endotoxin has been positively associated 
with serum CRP in overweight but not in lean individuals, a high fat meal fed to morbidly obese 
individuals increased postprandial endotoxin without concomitant increase in CRP (260, 261).   
Plasma from 201 men revealed an association between total energy intake and 
endotoxemia but not the inflammatory marker, IL-6 (134). Conversely, overfeeding in young 
men resulted in a statistically significant increase in postprandial IL-6 which was associated with 
the ratio of LBP/sCD14 and not LPS, in 4 of the 18 men studied (262).  Moreover, while a high 
fat western diet increased postprandial endotoxin by 71% relative to before the meal, no 
change in multiple markers of inflammation was found (68).  
Endotoxemia: What is a normal blood endotoxin concentration? 
There is also the significant obstacle of defining, if there exists and what it would be in 
endotoxin units or mass per unit volume (EU/mL; pg/mL), a normal blood endotoxin 
concentration in humans and other species. Assay of blood of healthy, chronically-ill, surgery, 
and Gram-negative bacteremia patients has been reported to contain no detectable endotoxin 
(180, 263, 264). Blood from 34 abdominal surgery patients revealed normal presence of 
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endotoxin in portal but not systemic blood (265). Opposite evidence exists where the 
concentration of endotoxin in the plasma of 116 healthy donors averaged 0.128±0.215 EU/mL 
(266). Similar values were reported  for normal weight (range 0.72-1.31 EU/mL)) and obese 
(range 0.96-1.51 EU/mL) individuals (267).  However, endotoxin exceeded 47 EU/mL in the 
plasma of 911 type-1 diabetes patients. In a separate study which investigated the endotoxin 
concentration in fasted and fed plasma samples of 30 healthy individuals, only 1 out of 30 and 7 
out of 30 had detectable endotoxin in fasted and fed states, respectively (268). Such extensive 
variation in the reporting of blood endotoxin values is further confused as subclinical endotoxin 
in 30 healthy individuals ranged from 0.01 – 125.33 EU/mL (67). The idea of chronic 
endotoxemia is therefore problematic as it assumes a normally circulating blood endotoxin 
concentration, fluctuations in which associate with metabolic disease and inflammation. To 
what extent endotoxemia occurs following ingestion of a high fat meal but not during an 
episode of Gram-negative bacteremia is an odd consideration. 
Conclusion 
Under conditions of high fat feeding, exogenous purified LPS fed to animals has been 
shown to be taken up into enterocytes. However, evidence is less clear whether endogenous 
native LPS from the gut microbiota contribute to the appearance of LPS in the bloodstream 
during the postprandial period. Increased as well as decreased endotoxemia has been 
separately observed following high fat feeding. The extent to which dietary fatty acid 
composition might modulate postprandial fluctuations in blood LPS, and how this is related to 
low-grade inflammation, is an unresolved topic.  As such, further investigation is required 
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before any firm role may be assigned to dietary fatty acids in modulating absorption along the 
intestinal epithelium and subsequent endotoxemia-associated inflammation.   
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ABSTRACT 
High-fat diets may contribute to metabolic disease via postprandial changes in serum 
endotoxin and inflammation. It is unclear how dietary fat composition may alter these 
parameters. To determine whether a meal that differs in fatty acid composition influences 
postprandial serum endotoxin concentrations and systemic inflammation in healthy adults. 
Healthy adults (n=20; mean age 25 ± 3.2 S.D. years) were enrolled in this single-blind, 
randomized, cross-over study. Participants reported to the laboratory, after an overnight fast, 
on four occasions separated by at least one week.  Participants consumed one of four 
isoenergetic meals that provided: 1) 20% fat (control; olive oil) or 35% fat provided from 2) n-3 
(ω3) (DHA = 500mg; fish oil); 3) n-6 (ω6) (7.4 g; grapeseed oil) or 4) saturated fat (16 g; coconut 
oil). Baseline and postprandial blood samples were collected. Serum was analyzed for 
metabolites, inflammatory markers, and endotoxin.  Data were analyzed using repeated-
measures ANOVA. Serum endotoxin concentration was elevated and attenuated after the 
saturated fat and n-3 fat meals, respectively (p<0.05). The n-6 meal did not differ from control. 
There was no treatment effect on markers of inflammation. Postprandial serum triacylglycerols 
were significantly higher after the n-6 meal compared to the n-3 meal. Non-esterified fatty 
acids were significantly elevated following the saturated fat meal compared to other treatment 
meals. Meal fatty acid composition modulates postprandial serum endotoxin concentration in 
healthy adults. However, postprandial endotoxin was not associated with systemic 
inflammation in vivo. This study was registered at clinicaltrials.gov as NCT02521779. 
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INTRODUCTION  
In recent years, accumulating research has demonstrated a link between dietary fat and 
endogenous endotoxin in relation to metabolic inflammation (1; 2). Current evidence suggests 
that dietary fat modulates plasma endotoxin concentration which is associated with low-grade 
systemic inflammation and is implicated in the development of dysregulated metabolism (3; 4; 
5; 6). Endotoxin, also known synonymously as lipopolysaccharide (LPS), is considered a major 
predisposing factor for inflammation-associated diseases such as atherosclerosis, sepsis, 
obesity, type 2 diabetes and Alzheimer's (7; 8; 9).  However, the effect of dietary fat on blood 
endotoxin remains poorly understood as it is not known if it is the total fat content of a meal or 
its fatty acid composition which exerts the primary effect.  
 Previous studies have shown that consuming a high fat meal (50g fat) is associated with 
a post-prandial increase in plasma (4) and serum (10) endotoxin concentrations in adult 
humans.  Limited evidence also suggests that the type of fatty acid may be important with one 
study showing that consuming oleic acid-rich peanuts reduced serum endotoxin in healthy men 
compared to when they consumed standard peanuts (11). A recent study reported that, using 
an ex vivo swine intestine model, mucosal to serosal endotoxin transport was decreased with a 
high docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)-meal but increased after a 
saturated fatty acid rich (coconut oil)-meal; however, the inflammatory response in these 
animals was not investigated (12). 
 High-fat diets have been linked with elevated blood concentrations of multiple 
inflammatory markers including interleukin (IL)-6 (13), IL-8 (14), and tumor necrosis factor-α 
(TNF- α) (15). As bacterial endotoxin is recognized by the body’s innate immune system and is a 
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potent initiator of inflammation processes (16), a postprandial increase in circulating endotoxin 
offers a potential mechanistic explanation for the inflammatory response (4). However, while 
blood endotoxin concentration has been associated with incidence of inflammation (17) and 
metabolic dysfunction (18; 19), others have reported an in vitro, but not in vivo, postprandial 
relationship between blood endotoxin concentration and inflammation following the 
consumption of high-fat meals (4).  
 Because the link between dietary fat intake, endotoxin, and inflammation is unclear, the 
primary objective of this study was to determine the effect of dietary fatty acid composition on 
postprandial endotoxemia in healthy subjects. Based on a previous study (12) we hypothesized 
that postprandial endotoxin concentrations and markers of inflammation in healthy adults 
would be increased by meals high in saturated or n-6 fatty acids, but reduced by meals enriched 
in n-3 polyunsaturated fatty acids. Pre- and postprandial serum was assayed for endotoxin, 
inflammatory markers, and metabolites. 
EXPERIMENTAL METHODS 
Human subjects 
Male and female participants (Table 1) [(average age 25 y (SD: 3.2 y); average body mass 
index (BMI) 22.4 kg/m2 (SD: 2 kg/m2); average weight 65.6 kg (SD: 8 kg)] were recruited via a 
mass email to faculty, staff, and students of Iowa State University or through personal contact 
during Spring and Fall of 2014. Inclusion criteria were age between 18 and 40 y, BMI ≥ 19.9 and 
≤ 24.9, less than 2kg weight change in the previous 3 months and a willingness to eat the test 
meals. Exclusion criteria were the presence of acute or chronic disease, use of tobacco 
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products, consumption of more than 21 units of alcohol per week, use of anti-inflammatory 
medication, or a history of macronutrient malabsorption. 
This study was conducted according to the guidelines laid down in the Declaration of 
Helsinki and all procedures involving human subjects/patients were approved by the Iowa State 
University Institutional Review Board and was registered at clinicaltrials.gov as NCT02521779.  
Written informed consent was obtained from all subjects/patients.  
Study design 
This study used a randomized, single-blind, crossover design.  After being recruited to 
the study, participants (n=20) were randomized to a treatment order (Figure 1).  Participants 
were required to report to the laboratory first thing in the morning following an overnight fast 
of at least 12 hours on four separate occasions each separated by at least seven days. 
 On the evening before each test session, participants were required to eat a standardized meal 
that provided 50% of the participant’s estimated energy requirements and contained 50% 
carbohydrate, 15% protein, and 35% fat. The participant’s estimated daily energy requirements 
were determined using validated equations (20). On the morning of each test session, 
participants were required to arrive at the laboratory at 0715. An indwelling catheter was 
inserted into the antecubital vein of each participant’s non-dominant arm and a baseline blood 
draw (10mL) was taken (time point t=0). Participants were then provided with the relevant test 
meal that was consumed in its entirety within 15 minutes. On each occasion, participants were 
blinded to which treatment meal they would be provided that morning. All treatment meals 
were served in a uniform, visually indistinguishable fashion to avoid participant recognition of 
treatment meal. Participants remained in the laboratory for five and a half hours during which 
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additional blood draws (10mL per blood draw) were taken at time points t0+ 1, 2, 3, 4, and 5 
hours. During this time, participants were allowed to perform sedentary activities (e.g. watch 
television, use their computer) but were not allowed to consume any food or drink except 
water. Following the final blood draw at t0+ 5 hours, the indwelling catheter was removed and 
the participant permitted to leave the laboratory. 
Immediately following venipuncture, blood was allowed to clot in pyrogen-free blood 
collection tubes for 45 minutes, followed immediately by centrifugation (15 min, 2000 x g, 4oC), 
and stored in pyrogen-free tubes (Fisher Scientific, Pittsburgh, PA) at -80oC until further analysis 
or transferred into standard plastic screw-cap vials (Quest Diagnostics, Madison, NJ) according 
to company instructions for same-day pickup and shipment to Quest Diagnostics for analysis of 
serum metabolites. 
Test meals 
Each test meal provided 25% of the participant’s estimated daily energy requirements 
as determined using validated equations (20). The test meal was a porridge made with quick-
ready oatmeal (Hy-Vee Supermarkets, Ames, IA) prepared with water according to the 
manufacturer’s instructions. To this oatmeal, 1) coconut oil (Spectrum, Lake Success, NY), 2) 
olive oil (Crisco, Orville, OH), 3) grapeseed oil (Pompeian, Baltimore, MD) or 4) fish oil (Carlson, 
Arlington Heights, IL) was added  in order to provide each of the four test meals a unique 
macronutrient (Table 2) and fatty acid profile (Table 3). 60g ± 17g of hard-boiled egg (Crystal 
Farms 6 peeled hard-boiled eggs ready-to-eat, Lake Mills, WI), 201g ± 26g of fat-free skim milk 
(HyVee fat free skim milk, Des Moines, IA), and 184 g ± 33g of orange juice (Tropicana Pure 
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Premium No Pulp, Bradenton, FL) were served with the porridge.  The participants were 
required to eat the test meal in its entirety within 15 minutes of serving.  
Bomb calorimetry 
The energy (kcal/g) of each test meal was determined using bomb calorimetry. Each test 
meal was prepared identical as if it were to be served to a participant. Meals were 
homogenized using a food-grade commercial blender (Model HBH450, Hamilton Beach 
Commercial, Glen Allen, VA) on high setting for 1 min and then passed through a 2mm sieve 
(Advantech 2.00 mm USA standard testing sieve No. 10, New Berlin, WI). Aliquots were 
weighed and then lyophilized at -55oC using a Uni-Trap Model 10-100 (The Virtis Company, 
Gardiner, NY). Lyophilized samples were ground and passed through a 1mm screen before 
being pelleted into duplicate ~1.00g pellets using a manual pellet press (Parr Instrument Co., 
Moline, IL). Pellets were placed within a model 1108 oxygen bomb (Parr Instrument Co.) and 
bombed in a 6200 Isoperibol calorimeter (Parr Instrument Co.). Each test meal was analyzed in 
duplicate with an accepted CV of less than 2% between duplicate samples. Calorimetry 
standard 1.00g benzoic acid pellets (Parr Instrument Co.) were used to calibrate each bomb 
before the analysis of test meal pellets.  
Limulus amebocyte lysate assays 
Participant serum and test meal endotoxin concentrations were determined using the 
kinetic chromogenic limulus amebocyte lysate (LAL) assay (Lonza, Switzerland). Endotoxin 
concentration was expressed as endotoxin units (EU) per mL. Meals were freshly-prepared 
identically as if they were to be served to a participant. Prepared meals were then placed into 
separate sterile Whirl-pak filter bags (Nasco, Fort Atkinson, WI) and homogenized in a 
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Stomacher 3500 (Seward, Davie, FL) for 2 minutes (21; 22).  Aliquots of the homogenized meal 
filtrate were collected into pyrogen-free tubes and stored at -80oC until analysis by the 
endotoxin assay. To minimize any impact of repeated freeze-thaw cycle on endotoxin-activity, 
serum and meal samples were thawed a single time for endotoxin assay.  A positive product 
control (PPC) recovery test of an endotoxin spike of known concentration was performed in 
serum and in homogenized meal filtrate per LAL kit manufacturer instructions (data not 
shown). A dilution ratio of homogenized meal filtrate or serum:LAL-grade water of 1:100 
provided a PPC recovery of the endotoxin spike within manufacturer recommendation of 50-
200%. Meticulous attention was given to the handling of serum and meal samples and the 
materials used in the endotoxin analysis to avoid contamination with exogenous endotoxin. 
Pipet tips, dilution tubes, 96-well microtiter plates, and reagent reservoir for use with a multi-
channel pipet were all certified to contain endotoxin concentrations < 0.005 EU/mL (Lonza, 
Switzerland).  
Participant serum and meal samples were diluted 1:100 in LAL-grade water (Lonza, 
Switzerland) and heated at 70oC for 15 minutes in order to heat-inactivate enzymatic activity 
that may affect endotoxin detection by the LAL method. 100 µL of each heat-treated serum and 
meal sample was plated in duplicate on endotoxin-free 96-well plates and incubated in a 
PowerWave HT microplate reader (Biotek, Winooski, VT) at 37oC for 10 minutes. At the 
completion of the incubation period, the plate was removed from the plate reader and 100 µL 
of LAL reagent was added to each sample well on the 96-well plate. The plate was then read at 
an absorbance of 405nm according to the LAL-assay manufacturer’s instructions. The assay 
result of each serum sample was accepted if the intra-assay CV between duplicate wells was 
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below 10%. Endotoxin concentrations were generated based on a standard curve constructed 
from a kit-supplied endotoxin standard prepared in LAL-grade water. The standard curve was 
constructed according to manufacturer’s instructions and provided an endotoxin detection 
range from 0.005 EU/mL – 50 EU/mL. All LAL-kits utilized in this study were verified as from the 
same manufacturing lot in order to eliminate potential impact on endotoxin measurements due 
to inter-lot kit variation. 
Biomarkers of inflammation assays 
A magnetic, fluorescent bead-based immunoassay (Bio-Plex pro human cytokine group I 
4-plex kit, Bio-Rad, Hercules, CA) was used to assay all serum samples for the cytokines IL-6, IL-
8, IL-10, and TNF-α. All Bio-Plex assays were performed on a Bio-Plex 200 system (Bio-Rad) and 
run according to manufacturer instructions. In brief, serum samples were diluted 1:4 in kit-
supplied sample diluent and run in duplicate on kit-supplied 96-well plates. A standard curve for 
each analyte was constructed from the kit-supplied lyophilized standard reconstituted in kit-
provided standard diluent and a minimum bead count of 50 beads per analyte was acquired for 
each well. Bio-Plex Manager software standard edition version 6.1 (Bio-Rad) was used to collect 
the mean fluorescent intensity of each cytokine-specific bead region and convert the data using 
the standard curve into reportable concentrations (pg/mL). The reported concentration of each 
analyte was the average between duplicate wells. 
C-reactive protein (CRP) content of each serum sample was determined via a 
nephelometric method performed by Quest Diagnostics (test ordering code 4420). CRP results 
were reported via delivered mail and expressed in mg/dL.  
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Metabolite assays 
All serum samples were assayed via spectrophotometric methods for concentrations of 
triacylglycerols (test ordering code 896) and non-esterified fatty acids (NEFA) (test ordering 
code 449) by Quest Diagnostics. Triacylglycerols are expressed in mg/dL, while NEFA are 
expressed as mmol/L.  
Fatty acid analysis 
Freshly-prepared porridge test meals were homogenized with egg, skim milk, and 
orange juice in a food-grade commercial blender (Model HBH450, Hamilton Beach Commercial, 
Glen Allen, VA) on high setting for 1 minute. Homogenized test meals were then passed 
through a 2.00 mm sieve (Advantech 2.00 mm USA standard testing sieve No. 10, New Berlin, 
WI) and aliquots were collected for immediate lipid extraction according to established 
methodology (23). Extracted lipids were dried under nitrogen gas before undergoing 
transesterification into fatty acid methyl esters using an acetyl chloride/methanol method (24).  
In brief, 1mL of methanol was added to 40mg of dried extracted lipids. Samples were then 
vortexed, during which 100 µL of acetyl chloride was added, and immediately purged under 
nitrogen gas and capped.  Samples were heated for 1 hour at 80oC, and then allowed to cool to 
room temperature. Esterified lipids were transferred to a gas chromatography vial, purged 
under nitrogen gas and stored at -20oC until injection into the gas chromatograph (GC). Unless 
otherwise noted, all chemical reagents were analytical standard-grade and purchased from 
Acros Organics (Bridgewater, NJ). 
Fatty acid methyl esters were analyzed in duplicate on a GC (Model 3800; Varian 
Analytical Instruments, Walnut Creek, CA) equipped with a SP-2380 (100 m x 0.25 mm I.D., 0.20 
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µm) capillary column (Supelco, Bellefonte, PA). Helium was the carrier gas with a flow rate of 2 
mL/min.  The GC injection port temperature was 220oC and operated in standard split/splitless 
mode. The GC oven was maintained at 70oC for 4 min, then increased to 175oC at a rate of 
13oC/min and isothermally held for 27 min, and then increased to a final temperature of 215oC 
at a rate of 4oC/min and isothermally held for 28 min. Test meal fatty acid profiles were 
analyzed using commercial software (Varian Star Chromatography Workstation Version 6.41, 
Walnut Creek, CA). Peak identification was validated by relative retention times with known 
reference standards (Supelco, Bellefonte, PA) and methyl tricosanoate (Nu-Chek Prep, Elysian, 
MN). 
Statistical analysis 
The primary outcome of this study was the effect of test meal fatty acid composition on 
postprandial serum endotoxin concentration. The secondary outcome was the effect of the test 
meal on the serum postprandial concentration of biomarkers of inflammation and metabolites. 
Mean and standard error were calculated for all study variables. Treatment effects of the test 
meal on serum endotoxin, inflammatory markers and metabolites were analyzed using a mixed 
model ANCOVA using treatment and time point as repeated measures and baseline as a 
covariate. All post-hoc, pairwise comparisons were performed using Bonferroni adjustments.  
Data was analyzed using SPSS software (version 22; IBM, Armonk, NY).  Statistical significance 
was set at p < 0.05. A power calculation was conducted and it was estimated that a sample size 
of 16 individuals would be sufficient to detect a one SD difference with α = 0.05 and β = .80. 
Participants were randomly assigned to treatment sequence using a Latin Square design.  
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RESULTS 
Test meal fatty acid profiles 
The unique fatty acid compositions of each of the four test meals are presented in Table 
3.  The saturated fat test meal contained a high percentage (60.7%) of several saturated fatty 
acids found in coconut oil including lauric, myristic, and palmitic fatty acids. Compared to the 
saturated fat meal, the n-3 test meal contained a lower total percentage of saturated fatty 
acids (32.6%). Moreover, the n-3 test meal contained both docosahexaenoic and 
eicosapentaenoic omega-3 fatty acids that were not present in the saturated fat meal. The low-
fat test meal primarily contained fatty acids found in olive oil, including oleic (57.3%), palmitic 
(16.4%), and linoleic (16.8%) acids. The n-6 test meal contained a high percentage of fatty acids 
found in grapeseed oil including linoleic (31.2%), oleic (31.4%), palmitic (14.2%), and stearic 
(5.0%) acids 
Test meal energy and endotoxin contents 
The energy content (kcal/g) and endotoxin (EU/g) contents of each of the four test 
meals is reported in Table 2. The mean energy content of the four test meals was 5.0 ± 0.04 
kcal/g (dry weight basis). The meal endotoxin concentrations ranged from 65.9 to 89.6 EU/g 
(Table 2).   
Kinetic chromogenic LAL assay of serum endotoxin 
All subjects, regardless of treatment group or day of laboratory visit, had detectable 
levels of endotoxin in their serum at baseline measurement. Average participant baseline 
endotoxin concentration was 0.365 ± 0.09 EU/mL. To ensure baseline endotoxin values were 
not the result of exogenous contamination from the materials used in the isolation of serum, 
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control vessels were included and assayed identical to the vessels that contained human tissue. 
All control tubes had endotoxin levels of <0.005 EU/mL as measured by the LAL assay.  Accuracy 
of baseline endotoxin values was validated by repeat LAL assay of randomly selected baseline 
serum samples on two separate days via two separate LAL kits with the same manufacture lot 
number (data not shown). 
There was a significant main effect of test meal on serum endotoxin concentration (F(3, 
83)=3.104; p<0.05).  Post hoc analysis revealed that serum endotoxin was lower following the 
n-3 meal compared to the saturated fat meal (p<0.05).  Comparison of the mean endotoxin 
values of the three high fat diets to the low fat diet did not yield a statistically significant 
(p<0.05) difference suggesting that absolute fat intake does not influence post-prandial 
endotoxemia. In addition, there was a significant main effect of time on serum endotoxin (F(4, 
229)=2.972; p<0.05).  Post hoc analysis revealed a statistically significant difference between 
timepoints 60 minutes and 240 minutes and 120 minutes and 240 minutes (p<0.05).  The 
treatment x time interaction was not statistically significant. 
Quantitative determination of multiple serum biomarkers of systemic inflammation  
Participants’ baseline and postprandial serum concentrations of C-reactive protein 
measured below the detectable limit (< 0.10 mg/dL) of the assay performed by Quest 
Diagnostics. Fluorescent bead-based immunoassay (Bio-Plex) of each participant serum sample 
yielded undetectable concentrations of IL-6, IL-8, IL-10, and tumor necrosis factor-α (data not 
shown).   
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Measurement of serum triacylglycerol and non-esterified fatty acids 
 Mean postprandial serum concentrations of triacylglycerols and non-esterified fatty 
acids displayed similar change-from-baseline trends irrespective of test meal (Figure 2). The 
mean participant baseline measurement of serum triacylglycerols concentration (mg/dL) was 
89 ± 2. There was a significant main effect of treatment meal on serum triacylglycerols 
concentration (F(3, 58)=3.865; p<0.05). Post-hoc analysis indicated serum triacylglycerols 
concentration following the n-6 meal to be statistically higher (p<0.05) than after consumption 
of the n-3 meal (Figure 2A). A significant main effect was also found of time on triacylglycerols 
concentration (F(4, 255)=29.805; p<0.05). Post hoc analysis revealed a statistically significant 
difference between time points 60 minutes and 120 minutes, 60 minutes and 180 minutes, 60 
and 240 minutes, 120 minutes and 180 minutes, 120 minutes and 300 minutes, 180 minutes 
and 300 minutes, 240 minutes and 300 minutes. The treatment x time interaction was not 
statistically significant. 
Mean participant baseline concentration of NEFA (mmol/L) was 0.407 ± 0.019. A 
significant main effect was found for test meal (F(3, 105)=8.859; p<0.05) on serum NEFA 
concentration. A significant main effect was also found for time (F(4, 256)=179.456; p<0.05) on 
NEFA serum concentration (Figure 2B).  Following the saturated fat test meal NEFA serum 
concentration was significantly different (p<0.05) than had the participant consumed any of the 
other test meals. Post hoc analysis revealed a statistically significant difference between time 
points 60 minutes and 180 minutes, 60 minutes and 240 minutes, 60 minutes and 300 minutes, 
120 minutes and 180 minutes, 120 minutes and 240 minutes, 120 minutes and 300 minutes, 
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180 minutes and 240 minutes, 240 minutes and 300 minutes. Treatment meal x time point did 
not reach statistical significance. 
DISCUSSION 
               The results of this study demonstrate that the modulatory role of dietary fat intake on 
postprandial endogenous endotoxin concentration in healthy adult men and women is 
influenced by dietary fatty acid composition, but not the fat content of a meal. Although serum 
endotoxin was found to increase after a saturated fatty acid rich meal or decrease after an n-3 
PUFA enriched meal, markers of in vivo inflammation were unaffected. Whether an elevated 
blood endotoxin concentration following a single high-fat meal may lead to inflammation in 
people is unclear as other studies have reported an association (4; 10) while others did not find 
evidence linking postprandial endotoxin with inflammation (25). This inconsistently-described 
relationship may be, in part, explained because previous studies involving humans have not 
fully explored the role of dietary fat composition in mediating outcomes of postprandial 
endotoxin and inflammation. The present study therefore, to the best of our knowledge, is one 
of the initial studies to directly examine this relationship in humans.  
               A clearly observed trend was generated from the effect over time of test meal on 
subject postprandial serum endotoxin concentration (Figure 3). The low-fat meal, which 
provided 20% of its energy from fat, was included in this study in order to examine whether a 
meal’s percent energy from fat influenced postprandial endotoxin concentration. Notably, the 
higher-fat test meals, in which each meal provided 35% of calories from fat, were not different 
from the low-fat meal in their effect on postprandial serum endotoxin (data not shown). This 
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suggests that in an isoenergetic series of meals, a higher percentage of fat does not 
differentially alter postprandial serum endotoxin concentration.  
             Among the higher-fat test meals, we found that the fatty acid composition of the meal 
had a significant effect on postprandial outcome serum endotoxin (Figure 3). In particular, the 
saturated fat and n-3 fat meals elicited opposite effects on postprandial serum endotoxin. A 
similar relationship between saturated and n-3 fats on serum endotoxin has been previously 
demonstrated to occur in swine (12). However, in mice, a diet rich in saturated fat had no 
significant effect on postprandial endotoxin (26). The reasons why conflicting results would be 
obtained from different species is not entirely clear. The comparative similarity of study design 
between the swine study and the present study, which yielded similar results, included the 
selection of coconut oil as the saturated fat treatment, and fish oil as the n-3 fat treatment. 
Laugerette et al. (26) recently reported dissimilar findings when using milk-fat or palm, 
sunflower, and rape seed oils as dietary treatments. Specifically, saturated fat-rich palm oil 
resulted in the lowest blood endotoxin concentration whereas rapeseed oil, low in saturated 
fat, resulted in the highest blood endotoxin concentration. Another reason for conflicting 
results is that the measurement of serum endotoxin in swine and our present study followed 
ingestion of a single treatment meal, compared to mice that were fed for 8-weeks on differing 
dietary treatments and then endotoxemia assessed. Anatomical differences between species 
may also contribute to the different results obtained in each species (27; 28). For example, 
mouse intestinal tract physiology is less similar to human than is that of swine (29; 30; 31; 32).  
              That the n-6 meal raised postprandial endotoxin concentration but was not significantly 
different from other higher-fat treatments agrees with previous findings in swine where n-6-
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rich vegetable oil was not significantly different in treatment effect on serum endotoxin than n-
3 or saturated fat meals (12). The postprandial trend in our data for the effect of the n-6 meal 
where serum endotoxin appeared higher than that of the n-3 treatment but lower than the 
saturated fat-treatment, mirrors the treatment effect trend found in swine (12). 
  The intestinal epithelial interface is known to play a role in immune recognition 
between host and non-host (33). Toll-like receptor (TLR)-4 is one of the innate immune 
receptors involved in the recognition of the lipid A antigenic portion of endotoxin (34). Lipid A 
often contains saturated fatty acids common in human diets (34; 35; 36). While saturated fatty 
acids and n-3 PUFA have been demonstrated to reciprocally modulate human TLR-4 (34; 35), 
saturated non-esterified fatty acids (NEFA) in the blood of healthy Malaysian adults due to 
dietary fat intake did not increase inflammatory markers (36). Likewise, in our study, n-3 and 
saturated fat test meals were found to effect significantly different serum NEFA but not 
inflammatory marker outcomes. 
 Test meal fat composition and postprandial changes in serum endotoxin did not 
associate with in vivo inflammation in any of our serum samples. While serum endotoxin 
concentration did uniquely change during the postprandial phase of each test meal, none of the 
test meals of our study caused a significant rise in endotoxin concentration when compared to 
baseline measurement (Figure 3). One possibility for this observation was that the subjects 
were healthy, young, and fed only a single meal to assess postprandial endotoxin. Although a 
separate study reported a rise in plasma IL-6 at 120 minutes postprandial in healthy men after a 
single meal containing 33g fat (37), we did not observe an associated peak of IL-6. Similar to our 
findings, others have reported no association between serum endotoxin and IL-6 in healthy 
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men (5). An intake of approximately 24oz of orange juice was reported to blunt the pro-
inflammatory response and rise in circulating endotoxin following a high-fat meal (38). As the 
present study included less than 8oz of orange juice as part of each test meal, it is unlikely that 
orange juice contributed a significant anti-inflammatory effect. 
The occurrence of inflammation following feeding does not appear to be dependent on 
changes in blood endotoxin concentrations. While in the present study we did not find a 
significant rise in endotoxin concentration following the feeding of any of the treatment meals, 
other studies that found postprandial increases in blood endotoxin after consumption of a 
single high-fat meal, likewise, did not report changes in inflammation. In male smokers, plasma 
CRP concentration, an acute phase protein, was not found to increase following a high-fat meal 
despite a significant rise in postprandial endotoxin when compared to baseline measurement 
(4). Morbidly obese men that had measurable serum CRP before ingestion of a 50g fat meal, 
but following consumption had no increase in CRP despite a significant rise in serum endotoxin 
(10). The absence of inflammation, including no detectable CRP, in our samples may be, in part, 
due to the exclusion criteria in selecting for volunteers for the present study. Undetectable 
concentrations of TNF-α in human plasma have been previously reported to coincide with 
measurable increases in plasma endotoxin after a single high-fat meal that contained 50g of 
butter (4). Although endotoxin may induce in vitro IL-8 (39) and IL-10 (40) expression in human 
endothelial and Kupffer cells, respectively, we found no in vivo evidence of IL-8 or IL-10 in our 
samples. Likewise, a separate group also reported no association between in vivo measurement 
of IL-8 and the feeding of a high-fat meal in humans (25). This may suggest that human cell line 
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production of certain pro- and anti-inflammatory cytokines after in vitro challenge by 
exogenous endotoxin does not adequately mimic in vivo conditions after dietary fat intake. 
  
Conclusion 
In conclusion, our results demonstrate that while the composition of dietary fat, but not 
the percent calories from fat, are significant in determining postprandial changes in in vivo 
blood endotoxin concentrations, the feeding of a single meal is not capable of inducing 
endotoxin-related systemic inflammation in healthy adults. Future studies should investigate 
what long-term repeated consumption of such meals would effect in terms of blood endotoxin 
and presence of inflammation. 
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TABLES 
 
TABLE 1 
Demographics of subjects (n=20) that successfully completed the studya 
 Male Female  
Number of subjects 12 8  
Average age (y) 25 25  
Weight (kg) 68.9 59.4  
Body mass index  22.7 22.3  
a Participant information about race and ethnicity was not collected. 
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TABLE 2 
Treatment meal composition  
 Low-fat High fat 
 (n-3) 
High fat  
(n-6) 
High fat  
(saturated) 
Carbohydrate (%)a 65 50 50 50 
Protein (%) 15 15 15 15 
Total fat (%) 20 35 35 35 
Saturated fat (%) 5 10 10 15 
Total n-6 fatty acids 
(%) 
2 2 7 2 
EPA+DHA fatty acids 
(%) 
0 0.5 0 0 
 Mean SEM Mean SEM Mean SEM Mean SEM 
Energy (kcal/g)b 4.96 0.04 4.90 0.01 5.09 0.05 5.22 0.01 
Endotoxin (EU/g)c 89.66 3.29 72.97 1.07 72.72 0.63 65.98 0.51 
a Values (%) are based on 25% of participant estimated daily energy requirements. 
b Each test meal was bombed in duplicate as described in Methods.  
c Test meals were assayed in duplicate using LAL kinetic chromogenic endotoxin assay. 
 
89 
 
aAll values are expressed as percent of total fatty acids from a lipid extract prepared from 
duplicate samples of each test meal as described in the Methods. 
b - ; not detected 
 
 
 
 
TABLE 3 
Fatty acid composition of test mealsa,b 
Compound Common name Low-fat High fat  
(n3) 
High fat 
 (n6) 
High fat  
(saturated) 
8:0 Caprylic - 1.1 - 2.9 
10:0 Capric - 0.9 1.1 2.7 
12:0 Lauric - 8.5 8.4 23.8 
14:0 Myristic 0.2 5.0 3.8 10.6 
16:0 Palmitic 16.4 17.1 14.2 15.9 
16:1 Palmitoleic 1.1 2.5 0.7 0.8 
18:0 Stearic 4.3 4.9 5.0 4.7 
18:1 n9 cis Oleic 57.3 35.6 31.4 24.8 
18:2 n6 cis Linoleic 16.8 13.0 31.2 10.3 
20:0 Arachidic 0.2 0.1 0.1 0.1 
18:3 n3 α-Linolenic 0.8 0.7 0.5 0.4 
20:1 n9 Eicosenoic 0.3 0.4 0.2 0.2 
20:4 n6 Arachidonic 0.6 0.8 0.6 0.7 
20:5 n3 Eicosapentaenoic - 3.0 - - 
22:6 n3 Docosahexaenoic - 2.3 - - 
Other  2.0 4.1 2.8 2.1 
n-6:n-3   21.7 2.3 63.6 27.5 
Saturated 
n-3 
n-6 
 
 
21.1 
0.8 
17.4 
32.6 
6 
13.8 
32.6 
0.5 
31.8 
60.7 
0.4 
11 
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FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1. Flow chart of subjects (n=20) through the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 Subjects randomized to order of treatment groups in crossover study design 
Saturated Fat 
Treatment Meal 
Omega-6      
Treatment Meal 
Omega-3        
Treatment Meal 
Low fat 
Treatment Meal 
20 Subjects received intended treatments 
All 20 subjects completed the study protocol and serum was collected and 
analyzed for primary and secondary outcomes 
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FIGURE 2.  Change from baseline effect of treatment meals on postprandial serum metabolite 
concentrations (mean ± SEM). (A): Triacylglycerol (mg/dL). (B): Non-esterified fatty acids 
(mmol/L). Participant serum triacylglycerol and non-esterified fatty acids were analyzed via 
spectrophotometric methods. Repeated measures ANCOVA with baseline as a covariate was 
performed with posthoc analysis as described in Methods. Serum triacylglycerols were 
significantly elevated (p < 0.05) following the n-6 fatty acid rich test meal when compared to 
the n-3 fatty acid rich meal. Serum non-esterified fatty acids were significantly higher (p < 0.05) 
in the saturated fatty acid rich meal compared to the other test meals. 
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FIGURE 3.  The effect of treatment meal on participant postprandial serum endotoxin 
concentration over time (mean ± SEM). Serum endotoxin was determined in duplicate using the 
kinetic chromogenic LAL endotoxin assay. Treatment effect was analyzed using repeated 
measures ANCOVA with baseline as a covariate as described in Methods. The n-3 fatty acid rich 
test meal effected a significantly lower (p < 0.05) postprandial serum endotoxin than the 
saturated fatty acid rich test meal. 
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CHAPTER 4. PURIFIED AND NATIVE FORMS OF LIPOPOLYSACCHARIDE ELICIT DIFFERENT 
CYTOKINE RESPONSE BY IPEC-J2 CELLS IN THE PRESENCE OF COMMON DIETARY FATTY ACIDS1  
Joshua M. Lyte, James H. Hollis and Nicholas K. Gabler 
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1Abbreviations: Lipopolysaccharide (LPS); Purified lipopolysaccharide (pLPS); Native 
lipopolysaccharide (nLPS); Docosahexaenoic acid (DHA); Arachidonic acid (AA); Lauric acid (LA); 
Polyunsaturated fatty acids (PUFA); Intestinal porcine epithelial cell-jejunum (IPEC-J2); 
lipopolysaccharide binding protein (LBP) 
 
Keywords: Lipopolysaccharide; Endotoxin; Inflammation; Lipid; IPEC-J2; Cytokine 
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ABSTRACT  
Scope: Dietary fatty acids have been reported to modulate intestinal epithelial inflammation 
from LPS and, separately, affect postprandial endotoxemia via altered LPS translocation in vivo. 
Since the intestine does not contain purified LPS (pLPS), we utilized the porcine small intestinal 
epithelial cell line, IPEC-J2, to determine whether fatty acids modulate epithelial inflammatory 
response differently depending on presentation of live bacteria, native LPS (nLPS), or pLPS, and 
if this is linked to LPS translocation.  
Methods and results: Confluent, polarized IPEC-J2 monolayers grown on Transwell® inserts 
were apically treated with control vehicle, lauric, arachidonic, or docosahexaenoic acid before 
apical addition of live, native, or E. coli K-12 pLPS. Selective inhibitors were used to determine 
fatty acid mechanism in modulating cellular response. pLPS elicited a unique (p<0.05) IL-6 and 
IL-8, but not tumor necrosis factor-α release compared to whole bacteria or nLPS. 
Polyunsaturated fatty acids (PUFA) reduced (p<0.05) cytokine secretion compared to lauric acid 
or control vehicle.  PUFA anti-inflammatory effect was found to act via a toll-like receptor 4-
dependent pathway.  
Conclusions: Our results demonstrate that use of in vivo-relevant forms of LPS may represent a 
novel tool to examine the mechanism by which common dietary fatty acids modulate gut 
inflammation in vivo.  
1. Introduction  
Purified lipopolysaccharide (pLPS) is well recognized in eliciting inflammatory responses 
in muscle [1], adipocytes [2], hepatocytes [3] and in intestinal epithelial cells in vitro and in vivo 
[4, 5]. Likewise, dietary saturated and polyunsaturated fatty acids (PUFA) have been 
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demonstrated to differentially modulate the activation of the major mammalian LPS receptor, 
toll-like receptor (TLR)-4 [6]. Saturated fatty acids and pLPS activate TLR4, leading to the 
transcription of NF-kB and pro-inflammatory cytokines [7, 8]. Conversely, PUFA have been 
shown to attenuate the TLR4 signaling pathway in macrophages in vitro [8]. Both ω3 and ω6 
PUFA, including DHA and arachidonic acid, have been demonstrated to inhibit NF-kB activation 
in colonic intestinal epithelial cells [9].  
Pro-inflammatory cytokine secretion via TLR4 activation can cause increased intestinal 
paracellular permeability through the dysregulation of enterocyte tight junctions [10, 11]. 
Although PUFA, such as DHA have been shown to reduce LPS translocation across the jejunum 
epithelium in intestinal explants ex vivo, whether this reduction is mediated, in part, via an anti-
inflammatory effect is unknown [12].  Although the small intestinal epithelium plays a 
significant role in dietary fatty acid absorption, enterocytes are also capable of mounting an 
inflammatory response to bacterial antigens [13, 14]. While enterocyte exposure to pLPS is 
well-recognized to elicit an inflammatory response altering epithelial integrity [15, 16], the 
impact of dietary saturated fatty acids or PUFA in modulating microbial-induced cytokine 
secretion is unknown. Furthermore, even though pLPS is widely used to elicit inflammation, it is 
important to consider that pLPS is not found in the in vivo gastrointestinal environment [17, 
18].  Instead, LPS exists as an endogenous structural component of the Gram-negative bacterial 
outer membrane, and within bacterial outer membrane vesicles or other cell membrane 
protein and lipid fragments. Although LPS must be extracted by LPS binding protein (LBP) and 
presented to the host immune receptor, lipoproteins and other membrane components have 
been shown to act synergistically with LPS in eliciting cytokine response [17-19]. Further to this 
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point, the polarized intestinal epithelial cell constitutively secretes LBP into the mucus layer and 
the luminally-directed release of LBP is enhanced upon apical stimulation of the epithelial cell 
[20]. Since LBP plays a major role in the host sensing of Gram-negative bacteria, the directional 
release of LBP is important in monitoring the mucosal microbiota [21].  
Critically, it is not known if the in vivo forms of LPS found in the gut, when it is part of a 
live bacterium or a bacterial fragment, elicit the same pro-inflammatory response by intestinal 
enterocytes. Although the very low expression of TLR4 in the intestinal epithelial cell 
contributes to microbial tolerance primarily in the colonic epithelium, LPS stimulation of human 
enterocytes has been shown to inhibit enterocyte proliferation which may lead to apoptosis 
and barrier dysfunction [22, 23]. The healthy human small intestinal mucosa, not the epithelial 
cell surface, is colonized primarily by Gram-positive bacteria [24]. Nevertheless, the enterocyte 
does express TLR4 in the Golgi apparatus and has been shown to internalize LPS-coated 
particles and viable Gram-negative bacteria [25, 26]. Since TLR4 stimulation in enterocytes has 
been suggested to play a critical role in the pathogenesis of small intestinal inflammation, it is 
important to examine if enterocyte-internalized LPS or whole bacteria elicit the same immune 
response and whether enterocyte absorption of TLR4-modulatory dietary saturated fatty acids 
and PUFA acts to enhance or mitigate LPS-induced TLR4-inflammation in the small intestinal 
epithelium [27]. Therefore, utilizing porcine jejunum derived intestinal epithelial cells (IPEC-J2), 
our objective was to determine the inflammatory response of these cells when presented with 
native and purified forms of LPS, and in the presence of saturated or n-3 PUFAs. We 
hypothesized that the pre-treatment of IPEC-J2 cells with PUFA or saturated fatty acid would 
decrease and increase constitutive and microbial-induced cytokine secretion, respectively. We 
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also postulated that the magnitude of cytokine response would be greater following challenge 
using whole bacteria or native LPS compared to purified LPS. 
2. Materials and methods 
2.1 IPEC-J2 cell culture 
 During all culture conditions, IPEC-J2 cells were maintained at 37oC in a 5% CO2 
atmosphere. IPEC-J2 cells were seeded in 162cm2 culture flasks (Corning, Corning, NY) 
containing growth media consisting of low-glucose Dulbecco’s Modified Eagle media (Sigma-
Aldrich, St. Louis, MO) supplemented with 5% fetal bovine serum (Atlanta Biologicals, Flowery 
Branch, GA), 1% antibiotic-antimycotic solution (Sigma-Aldrich), and 1 ng/mL murine 
recombinant epidermal growth factor (Fisher-Scientific, Pittsburgh, PA). All media used in this 
study was prepared in LPS-free water (Lonza, Switzerland). When cells reached 60-80% 
confluent, they were dislodged using sterile 0.05% Trypsin (Hyclone Laboratories, Logan, UT), 
centrifuged (800 x g, 10 min, 25oC) and re-suspended in growth media before being seeded at 
0.5mL of 3x105 cells/well onto the apical surface of 12mm, 0.4 µm pore-size, Transwell® 
permeable supports (Corning). Cells were allowed to adhere to Transwell® membranes for 24 h 
before the first media change. Transepithelial electrical resistance (TEER) of each well was 
measured using an EVOM2 epithelial voltohmmeter (World Precision Instruments, Sarasota, FL) 
on alternate days immediately before culture media change. IPEC-J2 monolayers were deemed 
confluent when TEER exceeded 1kΩ. All tissue-culture plates, tubes, multichannel reservoirs, 
and pipet tips were certified pyrogen-free. 
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2.2 Preparation of fatty acid solutions 
 Sodium salts (>99% pure) of DHA, lauric acid (LA), and arachidonic acid (AA) were 
purchased from Nu Chek Prep Inc. (Elysian, MN). Stock solutions of 1M of each fatty acid were 
prepared in antibiotic-antimycotic-free IPEC-J2 cell culture media and 0.2 µm sterile filtered 
(Millipore, Billerica, MA) immediately before conducting IPEC-J2 experiments.  
2.3 Cell proliferation assay 
 To determine any effect on cell viability from the sodium salt fatty acids 
abovementioned, IPEC-J2 cells were seeded at 104 cells/well onto a 96-well plate (Fisher-
Scientific) as described elsewhere [28] in antibiotic-antimycotic-free growth media with or 
without supplemental 50, 100, 150, 200 or 300 µM of sodium salt DHA, LA, or AA (Nu Chek Prep 
Inc.). Cells were then allowed to adhere for 24 h before addition of water-soluble tetrazolium 
(WST)-1 reagent (Roche, Indianapolis, IN). WST-1 reagent was incubated with cells for 1 h 
before absorbance was measured at 450/630 nm using a plate reader (BioTek Synergy 4, 
Winooski, VA) at 0.5, 1, 2, and 4 h time-points.  
2.4 Bacteria, native LPS, and purified LPS  
 The Escherichia coli K-12 strain MG1655 was grown overnight in Luria broth to 
stationary phase. Prior to addition into cell culture media, bacteria were washed 2x in 
phosphate-buffered saline and re-suspended at a density of 1x1010 CFU/mL as determined by 
optical density at 600 nm. Live bacteria were inoculated into antibiotic-antimycotic-free IPEC-J2 
growth media at a density of 109 CFU/mL immediately before use in IPEC-J2 experiments. To 
produce nLPS, suspensions of live E. coli K12 were sonicated using a microtip sonicator 
(Ultrasonic Processor Part no. S-4000, Misonix Inc., Farmingdale, NY) for 3 sequential rounds of 
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30 sec intervals each of 50A, 75A, and 100A. The microtip was first cleaned in 70% ethanol, and 
then used to sonicate the sterile antibiotic-antimycotic-free growth media before sonication of 
bacteria. Purified E. coli K-12 LPS (InvivoGen, San Diego, CA) and O55:B5 LPS (Sigma-Aldrich) 
were stored at -20oC until use. Both lyophilized LPS were reconstituted as separate stock 
solutions of 1mg/mL in LPS-free water (Lonza, Switzerland) immediately before use in IPEC-J2 
experiments. 
2.5 IPEC-J2 experiments 
 2.5.1 Modulatory effect of fatty acids on IPEC-J2 to different bacterial challenges 
 All IPEC-J2 monolayers were confirmed to have TEER exceeding 1 kΩ before 
experiments were begun. Both the apical and basolateral compartments of confluent IPEC-J2 
monolayers were refreshed with antibiotic-antimycotic-free growth media 24 h before bacterial 
challenge while only the apical compartment was supplemented with or without 100 µM DHA, 
LA, or AA.  In order to determine the effect of supplemental fatty acids on IPEC-J2 cytokine 
secretion under normal growth conditions, following 24 h incubation of monolayers with or 
without fatty acids, apical and basolateral media were collected from monolayers (n=3 per 
control and each fatty acid treatment) into microcentrifuge tubes and centrifuged (13,000 x g, 5 
min, 4oC) to remove cellular debris and the supernatant was stored at -80oC until cytokine 
assays.  
In a separate set of identical experiments, 24 h after incubation with or without fatty 
acids, instead of collecting media, live bacteria, sonicated bacteria, O55:B5 LPS, or K-12 LPS 
were separately spiked into the apical well (n=3 monolayers per bacterial challenge for each 
control and fatty acid treatment) at a final concentration of 107 CFU/well, 107 CFU/well, 1 
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µg/mL, and 1 µg/mL, respectively. After 6 h of the inflammatory challenge, apical and 
basolateral media were collected and centrifuged, supernatant was stored at -80oC until 
cytokine assays.  
2.5.2 Fatty acid mode of action on altering IPEC-J2 response to bacterial challenge 
 A separate set of identical experiments were conducted but with a single additional step 
in order to evaluate a mode of action for the modulatory effect of fatty acids on IPEC-J2 
response. Immediately following 24 h apical incubation with control vehicle or 100 µM DHA or 
LA a known highly selective inhibitor of either NF-kB (25 µM, BMS-345541, Sigma-Aldrich), TLR-
4 (10 µg/mL, ultrapure R. sphaeroides LPS, Invivogen), or AP-1 (10 µM, UO126, EMD-Millipore, 
Billerica, Massachusetts) was added to the apical compartment and remained undisturbed for 
20 min [29-31]. At 20 min following addition of inhibitor, either control vehicle, live bacteria, or 
pLPS were added and the experiments were carried out exactly as above described. 
 To evaluate the effect of fatty acids on IPEC-J2 apical-to-basolateral flux of LPS, 20 
µg/mL of fluorescent-isothiocyanate (FITC)-LPS (E. coli O55:B5, Sigma-Aldrich) were added 
instead of E.coli K-12 preparations, immediately following 24 h apical incubation with control 
vehicle or fatty acids as earlier described. Differences in monolayer paracellular permeability 
due to bacteria, nLPS, or pLPS were assessed using apically-loaded 0.5 mg FITC-dextran (4kD, 
Sigma-Aldrich) and by measuring transepithelial electrical resistance (TEER). Equal volume 
aliquots were carefully taken from apical and basolateral compartments upon addition of FITC-
dextran or FITC-LPS, and then again at 1, 3, and 6 h. TEER measurements were made 
immediately before, and then at 1, 3, and 6 h following, the apical addition of bacterial 
challenge. Flux of FITC-dextran or FITC-LPS was monitored by the appearance of FITC in the 
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basolateral compartment. Aliquots were read at excitation/emission of 495 nm/525 nm using a 
Biotek Synergy 4 plate reader. 
2.6 Cytokine measurement 
 Porcine Quantikine interleukin (IL)-6, IL-8, and TNF-α ELISA kits were purchased from 
R&D Systems (Minneapolis, MN). Apical and basolateral cell supernatants were thawed a single 
time and assayed in triplicate according to manufacturer instructions for concentrations 
(pg/mL) of IL-6, IL-8, and TNF-α using a Biotek Synergy H1 plate reader. Values were accepted if 
the intra-assay CV was at or below 8%. 
2.7 Statistical analysis 
All analyses were performed using Graphpad Prism 6 software (La Jolla, CA). Treatment 
effects of fatty acid and immunogen as well as treatment interactions of the supplemental fatty 
acids, bacterial challenges, and inhibitors were analyzed using two-way ANOVA. TEER factors of 
time and fatty acid treatment, as well as the interaction, were analyzed using repeated 
measures two-way ANOVA. All post-hoc, pairwise comparisons were performed using Tukey 
adjustments. Data are expressed as mean ± SEM. A p-value of < 0.05 was considered 
statistically significant and tendency at a p-value of < 0.10 
 
3. Results and discussion  
 3.1 Fatty acid modulation of IPEC-J2 cytokine secretion 
 Fatty acids have been shown to augment and attenuate inflammatory signaling based 
on their classification as saturated fatty acids, n-3 or n-6 PUFA [32]. Therefore, in order to test 
the effects saturated and PUFA have on IPEC-J2, a dose FA titration viability assay was 
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conducted with different concentrations of LA, AA, and DHA. These FA were chosen since TLR4 
has been shown to be activated by medium chain saturated fatty acids but inhibited by long 
chain polyunsaturated fatty acids [6]. Fatty acid supplementation of 100 µM was used in the 
present study as IPEC-J2 cell viability was negatively affected at or above 150 µM FA 
supplementation (Figure 1). These results support the findings performed in human endothelial 
cells that 100 µM fatty acid concentrations of DHA, AA, and LA, are not cytotoxic [33, 34]. For 
cell viability, the treatment effects of concentration (µM) (p<0.0001) and fatty acid (p<0.0001), 
and their interaction (p=0.0001) were significant (Figure 1). Dose-response dependent 
cytotoxicity of dietary fatty acids in intestinal epithelial cell culture has also been demonstrated 
elsewhere and may help to explain why high-dose PUFA can worsen chronically-inflamed 
epithelial tissue [35, 36]. Although the modulatory effect of supplemental fatty acids on cellular 
production of inflammatory markers has been studied in other cell lines, to the best of our 
knowledge the present report is the first to explore fatty acid modulation of cytokine 
production in small intestine jejunum epithelial cell culture [33, 34]. 
We next sought to determine whether dietary fatty acids would alter IPEC-J2 
proinflammatory cytokine secretions. We chose IL-8 and IL-6 because these cytokines play a key 
role in LPS-induced inflammatory response in the intestinal epithelium and have been shown to 
be secreted by IPEC-J2 [37-39]. Constitutive production of IL-8 and IL-6 by IPEC-J2 under normal 
growth conditions has also been demonstrated elsewhere [32]; however, the effect of 
supplemental fatty acids on modulating this secretion was not previously investigated [32].  
Polarized intestinal epithelial cells express different distribution of TLR, including TLR4, at the 
apical membrane which is exposed to gut lumen content, and the basolateral membrane which 
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faces the lamina propia [40, 41]. The vectorial secretion of chemokines IL-8 and IL-6 has been 
shown to play an important role in the epithelial cell-initiated immune response. Basolateral 
secretion of IL-8 and other chemokines cause the recruitment and activation of sub-epithelial 
leukocytes [42-44]. Intestinal epithelial cell polarized secretion of IL-6 is largely directed 
towards the lumen in order to activate neutrophils to respond to microbial threats at the 
mucosal surface [45].  For example, in small intestinal bacterial overgrowth, epithelial cells 
directionally-secrete certain cytokines into the mucosa [46]. Likewise, IL-6 is secreted towards 
the site of viable Gram-negative bacterial challenge in polarized intestinal epithelial monolayers 
[47]. The directional release of cytokines can also modulate epithelial barrier integrity [48, 49]. 
Basolateral secretion of IL-8 attraction of leukocytes aids in microbial clearance but may also 
result in epithelial tissue destruction [50]. As such, we investigated whether apical (gut lumen 
content) microbial challenge induced the vectorial secretion of cytokines. Apical incubation of 
IPEC-J2 monolayers with either AA or DHA for 24 h significantly (p<0.05) reduced in excess of 
50% apical and basolateral concentrations of IL-8 but not IL-6 compared to control vehicle and 
LA (Figures 2 and 3). Similar to our observation in IPEC-J2 cells, n-6 AA and n-3 DHA fatty acids 
have also been reported to exert a strong anti-inflammatory effect in Caco-2 cells via inhibiting 
of transcription factor activation of NF-kB [9].  Since cellular response to LPS in vivo involves NF-
kB activation which leads to the production of TNF-α, we also investigated constitutive IPEC-J2 
production of TNF-α under normal growth conditions. However, detection of TNF-α protein in 
apical or basolateral media was at or below the porcine-specific ELISA detection limit (data not 
shown). Although IPEC-J2 transcribes TNF-α mRNA, in agreement with other reports [39, 51], 
we did not detect TNF-α protein in the media.  
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3.2 Polyunsaturated fatty acids reduce IPEC-J2 cytokine response to bacterial challenge 
The secretion of IL-8 and IL-6 into apical or basolateral compartments was significantly 
(p<0.05) reduced following 6 h apical bacterial challenge in IPEC-J2 monolayers pre-treated for 
24 h with AA or DHA compared to pre-treatment with LA or control vehicle (Fig. 2 and 3). For 
apical and basolateral secretion of IL-6 and IL-8, treatment effects of fatty acid (p<0.0001) and 
immunogen (p<0.0001), as well as their interaction (p<0.001) were significant (Figures 2 and 3). 
However, IL-8 and IL-6 concentrations did not significantly differ (p>0.05) between apical and 
basolateral compartments (Tables 1 and 2). Similar effects were seen in vitro in macrophages 
incubated with DHA before challenge with pLPS [52]. Use of live bacteria or nLPS elicited a 
significantly (p<0.05) greater IL-6 and IL-8 response than did pLPS (Tables 1 and 2). These results 
support previous findings where pLPS stimulated a lower IL-8 secretion by human monocytes 
than bacterial membrane fragments in which LPS was a component [18]. The synergistic effect 
of LPS, lipoprotein, and other components from Gram-negative bacteria have been reported to 
stimulate a more robust response compared to pLPS alone [53]. Regardless of type of bacterial 
challenge, IPEC-J2 TNF-α secretion was below the detectable limit of the assay (data not 
shown). Undetectable TNF-α protein has been reported by other groups that have stimulated 
IPEC-J2 cells with pathogenic bacteria [39].   
Live bacteria and nLPS challenges did not trigger significantly different proinflammatory 
cytokine responses from each other (Tables 1 and 2). Ultrasonic lysis of live bacteria was 
hypothesized to increase the availability of bacterial immunogenic components for IPEC-J2 
recognition, including the lipid A region of LPS, typically hidden in the interior of the bacterial 
plasma membrane. The absence of a significantly different response between nLPS and live 
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bacteria is not entirely surprising as LBP has been shown to be required to extract LPS from 
both bacterial fragments and viable bacteria. Lack of difference between cytokine secretion in 
response to sonicated and viable bacteria has been reported elsewhere [54-56]. Further to this 
point, nLPS preparation undoubtedly contained other antigens, such as lipoprotein that were 
part of the live bacteria, which have been shown to play a synergistic role eliciting cytokine 
response [19].  
The anti-inflammatory effect of PUFA was found to proceed via a TLR4-dependent 
pathway in IPEC-J2 challenged with live bacteria or pLPS (Tables 3 and 4). This supports earlier 
in vitro work which demonstrated DHA prevented LPS-induced TLR4 activation in murine 
macrophages [6]. BMS-345541, UO126, and RS-LPS are known selective inhibitors of distinct 
steps in the TLR4 pathway [29, 31, 57]. We used each of these inhibitors to evaluate whether 
the anti-inflammatory effect of PUFA occurred at the TLR4 receptor or a specific downstream 
site, such as NFkB or AP-1 activation, within the TLR4 pathway. We chose not to investigate 
nLPS or AA because significantly different effects on IPEC-J2 cells were not observed between 
live bacteria and nLPS nor DHA and AA. To directly assess whether PUFA prevent activation of 
TLR4, ultrapure RS-LPS, a highly specific competitive antagonist of TLR4, was used [57]. RS-LPS 
contains a penta-acylated lipid A region compared to the agonistic E.coli LPS hexa-acylated lipid 
A [58]. These results support other findings where penta-acylated E. coli LPS was used to 
specifically inhibit TLR4 dimerization in macrophages [59]. Monolayers treated with DHA alone 
were not different (p>0.05) than those incubated with DHA and then RS-LPS before pLPS 
challenge (Table 4). However, RS-LPS did effect a further reduction (p<0.05) following DHA 
treatment in monolayers challenged with live bacteria. This may be because live E.coli contain 
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multiple antigenic components other than LPS that also initiate secretion of IL-8 through 
pathways that do not involve TLR4 [31]. Incubation of monolayers with RS-LPS following 
treatment with control vehicle or LA effected a significant reduction in basolateral IL-8 
secretion compared to monolayers treated only with control vehicle or LA before challenge 
(Table 4).  Since signaling of TLR4 leads to downstream activation of NF-kB and AP-1, we also 
investigated whether inhibition of these transcription factors reduced IL-8 secretion beyond the 
effect of PUFA alone [7]. Whereas inhibition of NF-kB and AP-1 significantly (p<0.05) reduced 
IPEC-J2 basolateral IL-8 response after treatment with control vehicle or LA, further decreases 
were not seen in the DHA-treated monolayers challenged with pLPS (Table 4). Other groups 
which have investigated the effect of TLR4 inactivation on downstream signaling have likewise 
seen no activation of NF-kB [59]. The targeted inhibition of AP-1 using UO126 has also been 
reported to significantly blunt IL-8 secretion in response to E. coli pLPS activation of TLR4 in 
vitro [60]. As such, our results indicate DHA attenuates IPEC-J2 cytokine response to LPS by 
inhibiting activation of TLR4. Since TLR4 activation elicits downstream activation of NF-kB and 
AP-1, the DHA-induced inhibition of the TLR4 receptor may explain why selective inhibitors of 
NF-kB and AP-1 did not further blunt cytokine secretion. 
3.3 Pathogenicity of bacterial source of LPS does not alter IPEC-J2 cytokine response 
Although it has been reported that pathogenic and non-pathogenic bacteria elicit 
different cytokine response in colon-derived intestinal epithelial cells, it is unknown whether 
enterocytes similarly regulate cytokine secretion [61, 62]. As such, we also sought to determine 
IPEC-J2 cytokine response to pLPS based on the pathogenicity of the microorganism from which 
the LPS was extracted. As expected, a statistically significant difference was not found for IL-8 
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or IL-6 in response to pathogenic or non-pathogenic LPS (Tables 1 and 2). Since small intestine 
enterocytes play a vital role in host nutrient absorption, a large presence of bacteria, whether 
pathogenic or non-pathogenic, in the small intestine represents competition for nutrients [61]. 
The lower concentration of bacteria in the small intestine is partly maintained by host secretion 
of higher concentrations of luminal secreted antimicrobials, TLR4 expression, and related 
aspects compared to the colon [22, 63]. Tolerance of intestinal epithelial cells to luminal 
antigens such as LPS has been suggested to depend on regional TLR4 expression [64]. 
Enterocyte TLR4 has been shown to be more sensitive to LPS and expressed at higher levels 
compared to colonocytes, which may explain the observed similar cytokine response to both 
non-pathogenic and pathogenic E. coli LPS [65, 66].  
3.4 FITC-LPS or FITC-dextran do not cross the IPEC-J2 monolayer 
Absorption of bacterial antigens from the gut lumen is, in part, inhibited by an intact 
intestinal epithelium [67, 68]. TLR4 is the receptor at which LPS has been demonstrated to 
augment intestinal permeability, and saturated fatty acids and PUFA modulate inflammation [6, 
11].  Since inflammatory stimuli have been shown to disrupt epithelial integrity resulting in an 
increased epithelial paracellular permeability, we investigated whether changes in the 
transepithelial electrical resistance (TEER) across the monolayer were modulated by dietary 
fatty acids [69]. TEER is a widely-used measurement to assess the integrity of epithelial tight 
junctions in vitro [70]. For monolayer TEER, the factor of time (p<0.0001) was significant but not 
fatty acid treatment (p>0.10) or their interaction (p>0.10). Viable bacteria, nLPS, and pLPS 
apical challenge each reduced monolayer TEER compared to TEER before bacterial challenge 
(Figure 4). Monolayer pre-treatment with different dietary fatty acids did not protect against 
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TEER reduction. In order to determine whether these changes in TEER had functional 
consequence on monolayer paracellular permeability we assessed the apical-to-basolateral flux 
of FITC-LPS and 4kD FITC-dextran [71]. Under no condition was the appearance of FITC-LPS or 
FITC-dextran in the basolateral compartment observed (data not shown). The impermeability to 
flux of FITC molecules most likely is the result of the formation of a confluent monolayer. In an 
earlier study which evaluated the morphological and functional characteristics of IPEC-J2 
monolayers grown similarly in Transwell® inserts, confluency was associated with 
impermeability to apical-to-basolateral movement of horse-radish peroxidase [72]. Although 
IPEC-J2 has been characterized in multiple studies as an in vitro model of the small intestine 
epithelium in which to study inflammatory cytokine response, it is less representative of in vivo 
epithelial integrity [28, 51, 73-75]. Similar to our findings, IPEC-J2 are well-recognized to exhibit 
both high TEER that exceed 10kΩ and low rates of active transport (Figure 4) [28, 72]. For 
example, in order to evaluate the antagonistic effect of 1mM H2O2 on IPEC-J2 monolayer 
paracellular integrity, FITC-dextran was incubated with monolayers for 18 h before basolateral 
appearance of FITC-dextran was assessed [76].  
Further to this point, while FITC-LPS was observed to cross porcine jejunum segments ex 
vivo, in the present study FITC-LPS did not cross the IPEC-J2 polarized monolayer [12].  
However, that study did not examine a role for fatty acids in modulating intestinal epithelial 
inflammatory response, which has been separately reported to affect permeability in an in vitro 
model of the colonic epithelium [10]. The present study demonstrated that these fatty acids 
modulate inflammatory response of porcine jejunum epithelial cells in vitro independent of 
alterations in functional paracellular permeability. Although limitations are noted for the in vivo 
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similarity of IPEC-J2 monolayer integrity and active transport, it was previously demonstrated 
that the modulation of FITC-LPS transport across porcine jejunum tissue ex vivo by dietary fatty 
acids did not proceed via a paracellular pathway [12]. Hence, the absence of modulation of 
paracellular permeability in IPEC-J2 by cytokines studied here may be representative of the 
unaltered paracellular integrity seen ex vivo [12]. 
 
4. Concluding remarks 
 Production of pro-inflammatory cytokines by IPEC-J2 cells is modulated by common 
dietary fatty acids via a TLR4-dependent pathway. Although pLPS may be used to study the 
inflammatory response of the gut epithelium, we demonstrated herein using IPEC-J2 cells, that 
pLPS elicits a unique cytokine response compared to in vivo-relevant LPS challenges. Thus, pLPS 
may be limited in its translational relevance in the study of in vivo phenomenon. As such, these 
results warrant further investigation of the small intestine epithelium as a site-of-action for 
dietary fatty acid modulation of LPS-induced inflammation that may occur during LPS 
absorption from the gut lumen. 
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Figure 1. Effect of different concentrations (µM) of fatty acids in cell culture growth media on 
IPEC-J2 viability. Data (n=3/trt) are presented as mean ± SEM. Control group proliferation was 
set as 100%, values from treatment groups are expressed as % proliferation of treatment 
groups compared to control group. Asterisk (*) indicate concentration of fatty acid which 
significantly p<0.05 affected cell proliferation compared to control group 
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Figure 2. Dietary fatty acids modulate IL-8 secretion by porcine jejunum epithelial cells (IPEC-J2) 
in the absence of bacterial challenge or presence of live E. coli K12 (107CFU/well), native LPS 
(nLPS) E. coli K-12 (107CFU/well), purified LPS (pLPS) (1µg/mL) from E. coli K-12, or pLPS 
(1µg/mL) from E. coli O55:B5. Confluent IPEC-J2 monolayers were apically pre-treated for 24 h 
with control media or 100µM lauric, arachidonic, docosahexaenoic acids before apical bacterial 
challenge for 6 h. Apical (A) and basolateral (B) culture supernatants were assayed for IL-8. 
Results are expressed in mean ± SEM. For apical, fatty acid effect p<0.0001, immunogen effect 
p<0.0001, and fatty acid*immunogen interaction p<0.0001. For basolateral, fatty acid effect 
p<0.0001, immunogen effect p<0.0001, and fatty acid*immunogen interaction p=0.0007. 
Columns labelled with different superscript letters are statistically different (p<0.05). 
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 Figure 3. Dietary fatty acids modulate IL-6 secretion (pg/mL) by porcine jejunum epithelial cells 
(IPEC-J2) in the absence of bacterial challenge or presence of live E. coli K12 (107CFU/well), 
native LPS (nLPS) E. coli K-12 (107CFU/well), purified LPS (pLPS) (1µg/mL) from E. coli K-12, or 
purified LPS (1µg/mL) from E. coli O55:B5. Confluent IPEC-J2 monolayers were apically pre-
treated for 24 h with control media or 100µM lauric, arachidonic, docosahexaenoic acids before 
apical bacterial challenge for 6 h. Apical (A) and basolateral (B) culture supernatants were 
assayed for IL-6. For apical, fatty acid effect p<0.0001, immunogen effect p<0.0001, and fatty 
acid*immunogen interaction p=0.0008. For basolateral, fatty acid effect p<0.0001, immunogen 
effect p<0.0001, and fatty acid*immunogen interaction p=0.0002. Results are expressed in 
mean ± SEM. Columns labelled with different superscript letters are statistically different 
(p<0.05). 
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(A)       (B) 
(C)       (D) 
 
 
Figure 4. Bacterial challenge elicits a reduction in the transepithelial electrical resistance (TEER) 
(ohms/cm2) of IPEC-J2 monolayers over time. TEER was measured immediately before (0h) and 
then at 1, 3, and 6h after the apical addition of E. coli K-12 LPS (A), E. coli O55:B5 LPS (B), E. coli 
K-12 native LPS (C), or viable E. coli K-12 (D) challenge as described in Methods. Data are 
presented as mean ± SEM. Time-points labelled * are statistically different (p<0.05) compared 
to baseline measurement. 
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Tables 
 
Table 1. Magnitude of IL-8 secretion is dependent on the type of bacterial challenge 1,2 
 Control O55:B5 pLPS K-12 pLPS Live K-12 K-12 nLPS 
Apical 224.8 ± 11.6a 492.1 ± 67.1b 355.1 ± 46.3b 863.4 ± 25.5c 850.9 ± 21.2c 
Baso 134.6 ± 19.6a 520.1 ± 45.3b 514.0 ± 36.9b 878.6 ± 33.9c 824.3 ± 52.4c 
1 Data are reported as (pg/mL) mean ± SEM; IPEC-J2 monolayers were apically-
challenged with E. coli K-12 live, native LPS (nLPS), or purified LPS (pLPS), or E. coli 
O55:B5 purified LPS for 6 h before cell supernatant was collected and assayed for IL-8 as 
described in Methods.  
2 Values in the same row with different letters are statistically different (p<0.05) from 
each other. 
 
 
Table 2. Magnitude of IL-6 secretion is dependent on the type of bacterial challenge 1,2 
 Control O55:B5 pLPS K-12 pLPS Live K-12 K-12 nLPS 
Apical 9.5 ± 3.0a 50.7 ± 2.7b 54.9 ± 2.4b 88.9 ± 10.3c 94.5 ± 8.2c 
Basol 2.4 ± 0.6a 34.2 ± 1.6b 42.9 ± 3.7b 59.5 ± 1.5c 82.5 ± 11.7c 
1 Data are reported as (pg/mL) mean ± SEM; IPEC-J2 monolayers were apically-challenged 
with E. coli K-12 live, native LPS (nLPS), or purified LPS (pLPS), or E. coli O55:B5 purified 
LPS for 6 h before cell supernatant was collected and assayed for IL-6 as described in 
Methods. 
2 Values in the same row with different letters are statistically different (p<0.05) from 
each other. 
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Table 3.  Dietary polyunsaturated but not saturated fatty acids inhibit IPEC-J2 TLR4 pathway 
at the TLR4 receptor but not at the downstream sites NF-kB or AP-1 to mitigate apical IL-8 
secretion to bacterial or LPS challenge* 
 
Inhibitor Live pLPS 
 Control LA DHA Control LA DHA 
Control 699.5 ± 
132.4 
919.3  
± 86.5 
423.1 ± 
103.5a 
549.8 ± 
106.5 
357.6 ± 
72.1 
438.1 ± 
58.1a 
BMS-
345541 
270.6 ± 
66.51 
381.8 ± 
105.41 
382.6 ± 
107.3 
160.0 ± 
31.51 
194.0 ± 
33.8 
137.6 ± 
35.11 
UO126 535.1 ± 
54.0 
260.5 ± 
76.71,a 
161.3 ± 
35.7a 
239.1 ± 
55.81 
299.1 ± 
49.1 
122.6 ± 
54.91 
RS-LPS 518.0 ± 
61.0 
587.6 ± 
141.91 
197.6 ± 
48.8a 
128.0 ± 
38.41 
188.5 ± 
49.7 
217.0  
± 48.8 
* Data are presented as mean ± SEM. Values with 1 are significant at p<0.05 compared to 
control value within the same column; values with a are significantly different (p<0.05) from 
control within the same row; purified LPS (pLPS), lauric acid (LA),  RS-LPS (R. sphaeroides 
LPS). IPEC-J2 monolayers were apically-incubated with 100µM fatty acid or control vehicle 
for 24 h and then apically-supplemented with control vehicle or BMS-345541 (NFkB 
inhibitor), UO126 (AP-1 inhibitor), or RS-LPS (TLR4 antagonist) for 20 min immediately 
followed by apical-challenge using control vehicle, E. coli K-12 pLPS or whole bacteria for 6 
h at which cell supernatant was collected and assayed for IL-8 as described in Methods.  
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Table 4. Dietary polyunsaturated but not saturated fatty acids inhibit IPEC-J2 TLR4 pathway 
at the TLR4 receptor but not at the downstream sites NF-kB or AP-1 to mitigate basolateral 
IL-8 secretion to bacterial or LPS challenge* 
 
Inhibitor Live pLPS 
 Control LA DHA Control LA DHA 
Control 677.0 ± 
55.9 
884.5 ± 
110.7 
403.5 ± 
25.9a 
574.8 
 ± 55.9 
561.0 ± 
30.7 
252.8 ± 
19.2a 
BMS-
345541 
431.0 ± 
77.41 
442.0 ± 
76.01 
264.8  
± 68.7 
269.0 ± 
29.61 
178.5 ± 
27.21 
153.1 
 ± 33.4 
UO126 554.8 ± 
90.3 
543.3 ± 
29.91 
226.8 ± 
34.71,a 
172.1 ± 
23.91 
325.1 ± 
16.91 
162.6  
± 30.5 
RS-LPS 546.1 ± 
113.4 
643.5 ± 
33.21 
218.6 ± 
39.8a 
245.8 ±  
53.41 
162.5 ± 
33.21 
143.0 ± 
 13.4 
* Data are presented as mean ± SEM. Values with 1 are significant at p<0.05 compared to 
control value within the same column; values with a are significantly different (p<0.05) from 
control within the same row; purified LPS (pLPS), lauric acid (LA),  RS-LPS (R. sphaeroides 
LPS). IPEC-J2 monolayers were apically-incubated with 100µM fatty acid or control vehicle 
for 24 h and then apically-supplemented with control vehicle or BMS-345541 (NFkB 
inhibitor), UO126 (AP-1 inhibitor), or RS-LPS (TLR4 antagonist) for 20 min immediately 
followed by apical-challenge using control vehicle, E.coli K-12 pLPS or whole bacteria for 6 h 
at which cell supernatant was collected and assayed for IL-8 as described in Methods. 
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CHAPTER 5. DIETARY FATTY ACID COMPOSITION MODULATES THE TRANSLOCATION OF LIVE 
BACTERIA, BUT NOT PURIFIED LPS ACROSS THE PORCINE SMALL INTESTINE1 
Joshua M. Lyte, James H. Hollis and Nicholas K. Gabler 
 
This manuscript has been prepared for submission to Journal of Lipid Research 
 
 
 
 
 
 
 
 
 
 
 
 
1Abbreviations used: CFU, colony forming unit; CRP, C-reactive protein; CVD, cardiovascular 
disease; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; EU, endotoxin unit; FITC, 
fluorescein isothiocyanate; GC, gas chromatograph; LAL, limulus amebocyte lysate; LBP, 
lipopolysaccharide binding protein; LPS, lipopolysaccharide; ME, metabolizable energy; OD, 
optical density; TEER, trans-epithelial electrical resistance; TLR, toll-like receptor. 
 
125 
 
ABSTRACT 
The dietary fatty acid composition of a single meal may modulate uptake of bacterial 
lipopolysaccharide (LPS) from the intestinal lumen during the postprandial window ultimately 
leading to an increased or reduced concentration of LPS in the bloodstream. It is unclear to 
what extent the continuous long-term consumption of diets distinct in dietary fatty acid 
composition may alter intestinal permeability to LPS and subsequent systemic LPS presence, 
known as endotoxemia. To determine how the chronic intake of a diet with or without long-
chain (ω)-3 polyunsaturated fatty acids may impact endotoxemia and intestinal permeability to 
LPS, swine (n=12/treatment) were for 9 weeks maintained on one of three isoenergetic diets 
that contained 1) 20% energy from fat (without DHA/EPA) or 40% energy from fat 2) without 
DHA/EPA or 3) with DHA/EPA. At the end of 9 weeks, swine were sacrificed following collection 
of baseline and postprandial blood samples. Duplicate jejunum segments (n= 6) of each pig 
intestine were immediately mounted in Ussing chambers and assessed for luminal uptake of 
purified E. coli K-12 LPS and live E. coli K-12. The duplicate jejunum segment of each pig was 
pretreated with a known inhibitor of enterocyte binding of LPS or bacteria in order to elucidate 
a mechanism of action by which dietary fatty acids may modulate translocation of LPS or 
bacteria from the gut lumen across the intestinal epithelium.  Postprandial serum endotoxin 
concentration was different as the result of different dietary treatments (p>0.05). Purified LPS 
was not found to cross the intestinal epithelium ex vivo regardless of diet. However, live 
bacteria were observed to translocate from the mucosal to serosal side of the jejunum ex vivo 
via a toll-like receptor (TLR)-4 dependent pathway. Bacterial translocation was reduced 
(p<0.05) in DHA/EPA-fed swine compared to other diets. Long-term feeding of diets with 
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DHA/EPA does not modulate endotoxemia or LPS translocation but does alter bacterial 
translocation in the jejunum via a TLR-4 associated mechanism. 
 
Introduction 
Long-term feeding of very high fat diets has been demonstrated to initiate metabolic 
syndrome via an increased presence of bacterial lipopolysaccharide (LPS) in the bloodstream, 
known as endotoxemia (1). The acute modulation of LPS translocation across the small intestine 
epithelium during the postprandial period was previously shown to rely on the dietary fatty acid 
composition of a high fat meal (2). It is unclear if it is the simple dichotomy of high or low fat 
consumption, or if instead it is the dietary fatty acid composition of the high fat meal which 
sustains endotoxemia over a long-term time period to result in the onset of metabolic 
syndrome. Moreover, while the absorption of fatty acids across the small intestinal epithelium 
may increase or reduce systemic presence of LPS, it is unknown from where the LPS is derived 
as purified LPS does not exist in the intestinal lumen in vivo (3). Since LPS in the form of 
endotoxin is blebbed-off during bacterial growth or found in fragments of killed bacteria, the 
translocation of Gram negative bacteria across the intestinal epithelium has been proposed as 
the source of LPS in the bloodstream (4). Mechanistically, it remains unclear how fatty acids 
alter endotoxemia via changes in the intestinal epithelium and if these changes influence the 
uptake of luminal bacteria.  
Meals high in fat content have been demonstrated to increase postprandial 
endotoxemia with the gut microbiota as a proposed source of LPS (5, 6). More recently, dietary 
fatty acid composition has been identified as a primary determining factor of a meal raising or 
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lowering postprandial blood LPS concentration (2, 7). However, it is unknown if this modulatory 
effect is restricted to an acute meal or persists with long-term consumption of diets distinct in 
fatty acid composition. Dietary oils rich in saturated or polyunsaturated fatty acids, such as 
coconut oil and fish oil, have been shown to increase and reduce, respectively, the uptake of 
LPS across porcine intestinal segments ex vivo (2). Further to this point, saturated and 
polyunsaturated fatty acids have been reported as agonistic and antagonistic, respectively, of 
the canonical LPS receptor, toll-like receptor (TLR)-4 in vitro (8). Enterocytes are the main 
intestinal epithelial cells involved in nutrient absorption and also express TLR4 within the 
plasma membrane as well as the Golgi apparatus (9-11). As it is well-recognized that the 
composition of the intestinal enterocyte plasma membrane reflects the fatty acid profiles of 
foods consumed in the diet, it is reasonable to infer that dietary fatty acids may interact with 
enterocyte membrane-located TLR4 in vivo (12). 
Enterocyte endocytosis and translocation of Gram-negative bacteria has been 
demonstrated in vitro to occur via the TLR4 signaling pathway (13). As enterocytes in vivo 
express TLR4 towards the lumen of the small intestine, dietary fatty acid modulation of TLR4 
might regulate the transcytosis of lumen bacteria (9). TLR4-mediated inflammation at the 
intestinal epithelium has been noted to reduce epithelial barrier integrity through dysregulation 
of cellular tight junctions in vitro (14). Although inflammation may contribute to the disruption 
of epithelial tight junctions in vivo, whole bacteria are too large to transit between dysregulated 
enterocyte tight junctions, thereby further suggesting a role for dietary fatty acids in mediating 
transcytosis of bacteria (15).  
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It is unclear how the chronic consumption of diets unique in fatty acid composition may 
alter endotoxemia and intestinal uptake of secreted LPS, whole bacteria, or both. As such, the 
present study investigated if swine fed saturated-fat rich or ω-3-fat rich diets for 9 weeks 
exhibited increased or decreased blood endotoxin concentrations, respectively. Moreover, 
long-term consumption of saturated or ω-3 polyunsaturated dietary fatty acids was 
hypothesized to likewise reciprocally modulate porcine small intestinal transport of both 
luminal LPS and whole Gram negative bacteria via a transcellular TLR4-associated mechanism. 
 
Materials and Methods 
Animal use 
All experiments were approved by the Iowa State University Institutional Animal Care 
and Use Committee before the initiation of this work. Pigs were raised on a normal corn-
soybean diet that met or exceeded their nutrient requirements. 36 pigs (52.1 ± 1.01 kg 
bodyweight) were randomly assigned to one of three diets (n=12 pigs/diet) for the entire 
duration of the 9 week study. Pigs were fed a single meal each day between 0700 and 0900 
hours. All pigs were weighed weekly and meal size determined and adjusted based on 
metabolic body weight pig metabolic body weight was determined using swine NRC (2012) 
equation:  
Metabolizable energy (ME) calories/d = 197BW0.6  
This number was then multiplied by 2.7X to achieved similar energy intakes to ad libitum fed 
pigs. To determine the daily feed allowance, the ME requirements calculated were then divided 
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by the ME of each diet to give kg of feed offered per day. All feed refusals were weighed and 
recorded. 
Body composition 
Nine pigs from each of the three diets were randomly selected for longitudinal whole 
body composition analysis at the initiation, and then again at the end, of the study. At the start 
of the study, in order to ensure that the pigs remained motionless during scanning, each pig 
was anaesthetized via intramuscular injection (in mg of drug/kg of bodyweight: a mixture of 4.4 
mg/kg xylazine, 2.2mg/kg ketamine HCl, 4.4 mg/kg Telazol) immediately before placement on 
the bed of the Dual X-ray Absorptiometry (DXA) machine (Hologic Discovery, Bedford, MA). At 
the end of the 9 week study, pigs were sacrificed via captive-bolt gun and then immediately 
scanned. The difference between initial and final body compositions was used to calculate 
tissue accretion over the duration of the study. Onboard calibration curves were used for 
correction and data analysis.  
Diets 
The formulations of each diet are provided in Table 1. Briefly, diets were designed to 
provide 20% kcal from fat (low fat) or 40% kcal from fat (High fat). Additionally, a third high fat 
diet was formulated to provide x% DHA/EPA.  Each diet was initially constructed from a corn-
soybean mix and then supplemented with different amounts of lard and soybean oil with or 
without fish (menhaden) oil to provide the final 20% or 40% kcal from fat. Diets were not 
formulated to be isocaloric. Each of the three diets were analyzed for gross energy and fatty 
acid content.  Gross energy (kcal/g) of each diet (dry matter basis) was determined using a 
model 1108 oxygen bomb housed in a 6200 Isoperibol calorimeter (Parr instruments Co., 
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Moline, IL). Each diet was pelleted into duplicate ~1.00g pellets using a manual pellet press 
(Parr instruments Co.). The bomb was calibrated using 1.00g calorimetry standard benzoic acid 
pellets (Parr Instrument Co.) immediately before analysis of diet pellets. Each diet was bombed 
in duplicate with an accepted CV of less than 2% between duplicate samples. 
Fatty acid analysis of diets and jejunum 
Jejunum segments separate from those used in the Ussing chamber were also collected 
immediately after animal sacrifice, immediately snap-frozen in liquid nitrogen and stored at -
80OC until determination of the tissue fatty acid profile. 
Total lipids were extracted from each diet in duplicate and from each jejunum sample 
(n=5/diet) according to previous methodology (16). Nitrogen gas was used to dry extracted 
lipids which were then trans-esterified into fatty acid methyl esters using an acetyl 
chloride/methanol method without modification (17). Methyl esterified lipids were transferred 
into gas chromatography vials and purged under nitrogen gas. All samples were stored at -20oC 
until gas chromatographic analysis.  All chemical reagents were purchased from Acros Organics 
(Bridgewater, NJ) and of analytical standard-grade. 
Fatty acid methyl esters were analyzed in duplicate on a GC (Model 3800; Varian 
Analytical Instruments, Walnut Creek, CA) equipped with a SP-2380 (100 m x 0.25 mm I.D., 0.20 
µm) capillary column (Supelco, Bellefonte, PA). Helium was the carrier gas with a flow rate of 2 
mL/min.  The GC injection port temperature was 220oC and operated in standard split/splitless 
mode. The GC oven was maintained at 70oC for 4 min, then increased to 175oC at a rate of 
13oC/min and isothermally held for 27 min, and then increased to a final temperature of 215oC 
at a rate of 4oC/min and isothermally held for 28 min. Test meal fatty acid profiles were 
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analyzed using commercial software (Varian Star Chromatography Workstation Version 6.41, 
Walnut Creek, CA). Peak identification was validated by relative retention times with known 
reference standards (Supelco, Bellefonte, PA) and methyl tricosanoate (Nu-Chek Prep, Elysian, 
MN). 
Blood collection 
At 9 weeks, blood was collected from each pig of every dietary treatment. Blood 
samples were obtained via venipuncture of the jugular vein. Utmost care and attention was 
given to the prevention of endotoxin contamination in the handling of blood samples. Pigs were 
fasted overnight with ad libitum access to water before the day of blood collection. Blood was 
collected from each pig immediately before feeding of 1kg of the respective diet. Pigs were 
observed to voluntarily consume the entire meal. Pigs were then again bled at 1 hour after 
consumption of the meal. Immediately following collection of each blood sample, blood was 
allowed to clot in pyrogen-free blood collection tubes. Serum was separated via centrifugation 
(15min, 2000 x g, 4oC) and equal volume aliquots were then stored in pyrogen-free tubes at -
80oC until further analysis.  
Limulus amebocyte lysate assays 
Pig serum and diet endotoxin concentrations were determined using the kinetic 
chromogenic limulus amebocyte lysate (LAL) assay (Lonza, Switzerland). Endotoxin 
concentrations were expressed as endotoxin units (EU) per mL serum or g diet. In order to 
evaluate the endotoxin content of each diet as closely as possible to that ingested by the pigs, 
diet samples used in endotoxin analysis were retrieved from the containers in which each diet 
was stored immediately before being fed to pigs. Each diet sample was then transferred into 
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separate sterile Whirl-pak filter bags (Nasco, Fort Atkinson, WI) and homogenized in a 
Stomacher 3500 (Seward, Davie, FL) for 2 minutes (18, 19).  Aliquots of the homogenized meal 
filtrate were collected into pyrogen-free tubes and stored at -80oC until analysis by the LAL 
assay. Repeated freeze-thaws were avoided entirely as each serum and diet sample was 
thawed a single time for the LAL assay.  A positive product control (PPC) recovery test of an 
endotoxin spike of known concentration was performed in serum and in homogenized meal 
filtrate per LAL kit manufacturer instructions (data not shown). A dilution ratio of homogenized 
diet filtrate or serum:LAL-grade water of 1:100 provided a PPC recovery of the endotoxin spike 
within manufacturer recommendation of 50-200%. Serum and diet samples as well as the 
materials used in the endotoxin analysis were handled with particular care in order to avoid 
contamination with exogenous endotoxin. Pipet tips, dilution tubes, 96-well microtiter plates, 
and reagent reservoir for use with a multi-channel pipet were all certified to contain endotoxin 
concentrations < 0.005 EU/mL (Lonza, Switzerland).  
In brief, serum and diet samples were diluted 1:100 in LAL-grade water (Lonza, 
Switzerland) and heated at 70oC for 15 minutes in order to heat-inactivate enzymatic activity 
that may mask endotoxin detection by the LAL method. 100 µL of each heat-treated serum and 
meal sample was analyzed in duplicate on endotoxin-free 96-well plates and incubated in a 
PowerWave HT microplate reader (Biotek, Winooski, VT) at 37oC for 10 minutes. At the 
completion of the incubation period, the plate was removed from the plate reader and 100 µL 
of LAL reagent was added to each sample well on the 96-well plate. The plate was then read at 
an absorbance of 405nm according to the LAL-assay manufacturer’s instructions. The assay 
result of each serum sample was accepted if the intra-assay CV between duplicate wells was 
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below 10%. Endotoxin concentrations were generated based on a standard curve constructed 
from a kit-supplied endotoxin standard prepared in LAL-grade water. The standard curve was 
constructed according to manufacturer’s instructions and provided an endotoxin detection 
range from 0.005 EU/mL – 50 EU/mL. All LAL-kits utilized in this study were verified as from the 
same manufacturing lot in order to eliminate potential impact on endotoxin measurements due 
to inter-lot kit variation. 
Serum acute phase protein and insulin assays  
 Serum haptoglobin, C-reactive protein (CRP), lipopolysaccharide binding protein (LBP), 
and insulin were determined using porcine-specific commercial ELISAs according to 
manufacturer’s instructions (Haptoglobin and C-reactive protein purchased from Alpco, Salem, 
NH; LBP purchased from Enzo Life Sciences, Farmingdale, NY; Insulin purchased from R&D 
Systems). Immediately before sample analysis, serum samples were diluted 1:10000 
(haptoglobin), 1:2000 (CRP), 1:100 (LBP), or 1:4 (insulin) and then assayed in duplicate. All 
serum samples were thawed a single time in order to avoid repeated-freeze thaw cycles. 
Duplicate values were accepted if intra-assay CV was at or below 10%. 
Ussing chamber experiments 
Within each diet, each pig was randomly designated to receive one of two Ussing 
chamber treatments (n=6 pigs/Ussing chamber treatment) that would occur only after sacrifice 
at the end of the study. A kanamycin-resistant derivative of the E.coli strain K-12 MG1655 (F-
kanamycin) was kindly provided as a gift from Professor Gregory Phillips (Iowa State University 
Veterinary School of Medicine).  One day prior to their use, E. coli were spread plated onto LB 
agar plates containing 50 µg/ml kanamycin sulfate and incubated at 37oC.  On the day of the 
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experiment, bacteria were scraped from the plates and re-suspended into Krebs-Henseleit 
buffer at a final density of 1 x 109 CFU/mL as determined by O.D. absorbance at 600 nm. 
At the end of the 9 week feeding trial, pigs were sacrificed and jejunum segments of 
each pig were retrieved for use in modified Ussing chamber experiments according to previous 
methodology with minor modifications (2). Briefly, jejunum segments were immediately 
transferred into individual bottles of chilled Krebs-Henseleit buffer (25 mmol/L NaHCO3, 120 
mmol/L NaCl, 1mmol/L MgSO4, 6.4 mmol/L KCl, 2mmol/L CaCl2, and 0.32 mmol/L NaH2PO4; 
pH 7.4) under continuous aeration. The intestinal serosal outer layer was carefully removed 
before each jejunum segment was equally divided into two segments (0.71 cm2) so that the 
jejunum of each pig was mounted in duplicate into two separate but identical Ussing chambers 
(Physiologic Instruments Inc. San Diego, CA; World Precision Instruments. New Haven, CT). 
Mounted tissues were immediately immersed in 4mL Krebs-Henseleit buffer on both the 
serosal and mucosal sides that were maintained at 37oC and constantly aerated with 95% 
O2/5% CO2. Each chamber was connected to dual channel current and voltage electrodes to 
monitor the transepithelial electrical resistance (TEER) of intestinal segments exactly as 
previously described (2). 
The mounted duplicate tissues of each pig were incubated for 15 minutes on the 
mucosal side with control vehicle (Krebs-Henseleit buffer) or one of two inhibitors according to 
the random assignment made at the beginning of the study. Ultrapure Rhodobacter 
sphaeroides LPS (10µg/mL; Invivogen, San Diego, CA) and methyl beta-cyclo dextran (25 mM; 
Sigma-Aldrich, St. Louis, MO) were used as a TLR4-specific competitive antagonist and a lipid-
raft disruptor, respectively, of the jejunum epithelium (20, 21). After 15 minutes, the jejunum 
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epithelium was challenged on the mucosal side by simultaneous addition of 20 µg/mL 
fluorescein isothiocyanate (FITC)-LPS (E.coli O55:B5; Sigma-Aldrich) and 108CFU/mL live E.coli K-
12. Mucosal and serosal chamber aliquots were taken immediately upon mucosal addition of 
LPS and bacteria challenges. Aliquots were taken every 15 minutes thereafter for a total of 75 
minutes. Mucosal-to-serosal transport of FITC-LPS was determined by measuring the relative 
fluorescence of each aliquot at 495/525 (excitation/emission) on a fluorescent plate reader 
(Synergy 4, BioTek, Winooski, VT). 
E. coli K-12 translocation from mucosal-to-serosal chamber was quantified according to 
previous methodology with some modifications (22). At the end of the 75 minute run, serosal 
chamber content was collected, briefly vortexed and then 10 µL was immediately spread plated 
onto kanamycin sulfate-supplemented EMB agar and incubated overnight at 37oC. After the 
overnight growth, E. coli K-12 CFU were counted. 
Statistical analysis 
Study variables are expressed as mean ± SEM. Statistical analyses were performed using 
analysis of variance (ANOVA). All post-hoc comparisons were performed using Tukey 
adjustment.  Treatment effects of the test meal on serum endotoxin and body composition 
were assessed as repeated measures. Data was analyzed using Graphpad Prism 6 software (La 
Jolla, CA).  Statistical significance was set at a p-value < 0.05 whereas a p-value of < 0.10 was 
considered a trend. 
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Results 
Body composition 
 Measurements of animal body composition at the initiation and outcome of the 9 week 
dietary feeding trial are reported in Table 5. Average total body mass (kg) of pigs was not 
different between the 3 dietary treatment groups either at the beginning or end of the study. 
Average daily feed intake (kg of feed) was 1.79 ± 0.06, 1.74 ± 0.06, and 2.0 ± 0.07 for the high 
fat, high fat with DHA/EPA, and low fat diet groups, respectively. Likewise, bone mineral 
content, total fat and lean were not statistically different between groups at the outset or 
conclusion of the study. The low-fat diet group was found to have less (p<0.05) % body mass 
from fat compared to either high fat or high fat (with DHA/EPA) groups at the outcome of the 
study; all groups were not different (p>0.05) in % body mass from fat at the start of the study. 
Treatment diet characteristics 
 The total lipid content by weight of each diet is found in Table 1. The actual percent kcal 
from lipid in each diet provided to pigs each day was 41.87 ± 0.00, 22.38 ± 0.00, and 41.85 ± 
0.00 for high fat, low fat, and high fat (with DHA/EPA) diets, respectively. The average daily 
intake ratio of DHA and EPA fatty acids for low fat and high fat groups was 0 as neither diet 
provided DHA or EPA. Conversely, the high fat diet (with DHA/EPA) provided an average daily 
intake ratio (DHA:EPA) of 0.69. The mean energy (kcal/g; dry weight basis) and endotoxin 
(EU/g) contents of the 3 diets was 5.06 ± 0.01 and 275.74 ± 9.70, respectively (Table 1).     
Fatty acid analyses of diet and small intestine 
 The distinct fatty acid composition of each diet is presented in Table 2.  The high fat diet 
(with DHA/EPA) contained several fatty acids commonly found in fish oil, including DHA and 
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EPA. On the other hand, the high fat and low fat diets did not contain DHA or EPA. All diets 
contained fatty acids frequently found in lard and soybean oil, including oleic, linoleic, palmitic, 
and stearic acids. 
 The fatty acid profile of swine jejunum from each of the 3 dietary treatment groups at 
the outcome of the 9 week study is reported in Table 3. Total saturated fatty acids were similar 
among all dietary groups. The DHA and EPA content of jejunum from the high fat (with 
DHA/EPA) group was significantly (p<0.05) greater compared to jejunum from the high fat and 
low fat groups. Total ω3 and ω6 fatty acids were highest and lowest in the high fat (with 
DHA/EPA) group compared to the other dietary groups. Likewise, the ratio of ω6: ω3 highest in 
the high and low fat groups but lowest in the high fat (with DHA/EPA) group. 
Serum endotoxin and acute phase proteins 
 The fasted and fed serum endotoxin concentrations of swine at the conclusion of the 
study are presented in Figure 1. The mean fasted serum endotoxin concentrations (EU/mL) of 
swine from low fat, high fat, and high fat (with DHA/EPA) were 0.18 ± 0.00, 0.38 ± 0.03, and 
0.41 ± 0.06, respectively. At the fed state, serum endotoxin (EU/mL) of the high fat diet group 
had increased by 0.07, the high fat diet group with DHA/EPA increased by 0.09, and the low fat 
group did not change, 0.0. There was only a significant main treatment effect for diet 
(p=0.0341) where posthoc analysis revealed a significant difference between low fat and high 
fat with DHA/EPA (p=0.0461) and a trend between low fat and high fat groups (p=0.0809). 
Serum endotoxin was not observed (p>0.05) to change significantly from baseline in any of the 
groups 1 hour after consumption of 1kg of the respective diets. Blood endotoxin was not found 
to differ (p>0.05) between any of the groups at either the fasted or fed time-point. 
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 Fasted serum concentrations of haptoglobin, CRP, and LBP as well as fasted and fed 
serum insulin at the end of the study are shown in Figure 2. After 9 weeks of dietary feeding, 
serum haptoglobin, CRP, and LBP concentrations were did not significantly differ (p>0.05) 
between treatment groups. The mean serum haptoglobin (mg/mL) of swine from low fat, high 
fat, and high fat (with DHA/EPA) were 1.68 ± 0.55, 1.49 ± 0.29, and 1.60 ± 0.16, respectively. 
The mean serum CRP (µg/mL) from low fat, high fat, and high fat (with DHA/EPA) were 270.7 ± 
21.69, 265.0 ± 19.52, and 241.1 ± 22.77.  The mean serum LBP (µg/mL) from low fat, high fat, 
and high fat (with DHA/EPA) were, 3.40 ± 0.03, 3.40 ± 0.02, and 3.45 ± 0.01 respectively.  
Ussing chamber experiments 
 Translocation of E. coli K-12 and FITC-LPS across the porcine jejunum ex vivo is 
presented in Table 5. Live bacteria were found to cross the epithelium from mucosal to the 
serosal compartment of the Ussing chamber under all experimental conditions. Conversely, 
FITC-LPS was not found to cross the epithelium under any condition ex vivo. Control jejunum 
tissues from pigs (n=12/diet treatment) did not undergo ex vivo pre-treatment in the mucosal 
chamber with inhibitors. Of these control tissues, a significantly greater (p<0.05) amount of 
bacteria was found to translocate mucosal-to-serosal in the high fat group compared to low fat 
and high fat (with DHA/EPA) groups. To rule out differences in paracellular permeability of 
tissues from different dietary groups, TEER was not different between dietary groups (data not 
shown).  Control tissues from the low fat and high fat (with DHA/EPA) groups did not evidence 
significantly (p>0.05) different amounts of translocated bacteria.  
The effect of ex vivo pre-treatment of jejunum segments with molecular inhibitors in the 
mucosal compartment of the Ussing chamber on bacterial translocation is also found in Table 5. 
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Incubation with R. sphaeroides LPS significantly reduced (p<0.05) bacterial passage in the high 
fat group compared to no inhibitor pre-treatment. Although a reduction in bacteria that 
crossed the epithelium was found in both the high fat (with DHA/EPA) and low fat groups pre-
treated with R. sphaeroides LPS, the decreased concentration was not significantly different 
from that of the control tissues of each group (p>0.05).  Pre-treatment with methyl β-
cyclodextrin did not significantly modulate (p>0.05) bacterial translocation among the tissues 
from any of the different dietary groups compared to controls.  
Discussion 
Central to metabolic diseases such as obesity and insulin resistance is the association of 
low-grade inflammation and endotoxemia (1).  Dietary fat intake, and in particular, dietary fatty 
acid composition, has been identified as a modulating factor of blood endotoxin concentration 
(2). As such, our objectives were to understand how the long-term feeding of a low fat diet or a 
high fat diet rich in saturated or polyunsaturated fatty acids would alter long-term blood 
concentrations of endotoxin and markers of inflammation, and if these changes associated with 
an altered metabolic profile and body composition.  
The results of this study demonstrate the long-term consumption of diets distinct in 
fatty acid composition alters bacterial but not LPS translocation across the porcine small 
intestinal epithelium as well as postprandial endotoxemia. Although several studies have 
described, albeit inconsistently, an acute modulatory effect for a meal’s fatty acid profile on 
postprandial endotoxemia, limited attention has been given to the long-term impact on 
postprandial endotoxemia from the chronic consumption of a diet distinct in fatty acid 
composition. Further to this point, it is unknown whether it is endotoxin in the gut lumen, or 
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the translocation of Gram-negative bacteria across the epithelium, and by what mechanism 
might fatty acids modulate this migration, that results in the systemic appearance of LPS. The 
present study, to the best of our knowledge, is the first investigation to examine a potential 
mechanism by which habitual consumption of common dietary fatty acids may modulate 
bacterial or endotoxin uptake from the gut and whether this is related to postprandial 
endotoxemia in vivo. 
 Although dietary fatty acid composition was found to modulate the translocation of 
Gram-negative bacteria at the jejunum ex vivo, this finding was accompanied by dietary fat 
content changes in endotoxemia in vivo in pigs in either a fasted or fed state at the outcome of 
the study (Figure 1; Table 4). This is not surprising since even under extreme clinical cases of 
bacterial translocation, including Gram-negative bacteremia, endotoxemia may often be 
undetectable (23). And, endotoxemia was found to increase in people fed a high fat meal by a 
similar increment of ~0.1 EU/mL as we observed in pigs (5) (Figure 1). Similar to our findings, 
mice fed a high fat diet made from lard and corn oil for two weeks and then fed live 
fluorescently-tagged non-pathogenic E. coli (109CFU), were found have increased translocation 
of the gavaged bacteria through the small intestinal epithelium (24). However, the same study 
did not investigate whether the in vivo translocation of E. coli resulted in endotoxemia. 
Although bacterial migration across the gut epithelium is increasingly understood to normally 
occur in animals and people, the extent of translocation may differ among animal species and 
depend upon the bacterial species (25-27). Interestingly, nutritional modulation of bacterial 
uptake may be a common phenomenon among different animal species. As we observed in pigs 
fed diet containing DHA/EPA, intestinal bacterial translocation in rats was also demonstrated to 
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decrease as a result of dietary feeding of ω3 fatty acids (Table 5) (28). Moreover, separate 
investigations that both utilized healthy rat intestinal segments mounted in Ussing chambers 
saw greater than 103 CFU E. coli translocation to the serosal compartment at 120 min following 
addition of E. coli to the mucosal side of the chamber (29, 30). 
The absence of translocation of a commercially-purified LPS across the intestinal 
epithelium ex vivo regardless of dietary treatment is in agreement with several other studies 
that also assessed LPS transport through small intestinal segments mounted in Ussing chambers 
or fed LPS to live animals to study LPS uptake from the gut lumen (Table 4) (4, 31). Conversely, 
in a separate report, LPS was absorbed by enterocytes and packaged into chylomicrons in mice 
in vivo following gavage of a mix of dietary long-chain triglycerides and 1µg of purified LPS (32). 
Since purified LPS does not exist in vivo, but does form large micellar aggregates in aqueous 
environments, the action of the digestive system in response to dietary lipids may play an 
essential role in increasing purified LPS absorption (3, 33). However, how digestive 
emulsification affects absorption of native, non-chemically purified forms of LPS in vivo is less 
clear (34).  
Considering the diets fed to pigs in the present study did contain measurable levels of 
endotoxin and postprandial changes in endotoxemia were observed but very small (~0.1 
EU/mL), the availability of native forms of endotoxin in a meal bolus is likely very small (Table 
1). For example, a separate group investigated the effect of an 8oz glass of orange juice on 
postprandial endotoxemia healthy human volunteers. While the baseline blood endotoxin 
concentration of the volunteers ranged from 0.15-0.35 EU/mL and the orange juice contained 
55250 EU/mL, postprandial blood endotoxin did not exceed a 200% rise from baseline values at 
142 
 
any time-point in the study (35). Likewise, in mice gavaged with a mixture of lipid and 1µg 
purified LPS, only 0.2% of the 1µg of radiolabeled LPS appeared in the bloodstream. In a 
previous report from our laboratory, a single meal rich in saturated or ω3 fatty acids did 
increase and reduce, respectively, postprandial endotoxemia in pigs (2). Although it is well 
known that the digestive tract adapts to dietary changes, such as increased lipase or alkaline 
phosphatase secretion in response to high fat diets, whether dietary fatty acid modulation of 
postprandial endotoxemia is an acute effect that precedes these physiological adaptations 
should be a topic of future research (36, 37). For example, in mice fed chow or a series of ultra-
high fat diets that each differed in fatty acid composition for 8 weeks, at the outcome of the 
study endotoxemia in mice fed chow was only significantly different from one of the four 
treatment diets; the authors did not investigate the change in endotoxemia during the course 
of the study (7).  
Diet-induced endotoxemia has been suggested to cause systemic low-grade 
inflammation in vitro that in turn may increase risk of metabolic syndrome and cardiovascular 
disease (CVD) (5). However, in vivo the effect of a rise in postprandial blood endotoxin in people 
fed a single high fat meal has not been associated with increased inflammation (5). To 
understand what effect changes in endotoxemia from long-term feeding of high fat diet instead 
of a single meal may have on inflammation, we assessed serum acute phase proteins CRP, 
haptoglobin, and LBP since the elevation of these biomarkers is used to predict onset of 
metabolic syndrome and CVD, but how these proteins are increased under conditions of high 
fat diet-induced endotoxemia, is unclear (38-40). Although endotoxin was detectable in pig 
serum samples, differences in CRP, haptoglobin, and LBP were not found between dietary 
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treatment groups (Figure 2). Endotoxemia in diabetic patients is positively correlated with 
serum CRP concentration (41). Haptoglobin has been used as a biomarker of chronic 
inflammation in pigs during 10 consecutive days of intravenous LPS administration (42). 
Likewise, LBP has been proposed as a biomarker of endotoxemia-induced immune response 
and metabolic disorders (43). Although pig serum endotoxin did significantly differ between 
different high and low fat treatment groups, the change in endotoxin concentration may be too 
low to elicit changes in CRP, haptoglobin, and LBP concentrations thereby suggesting a limited 
role of dietary fat intake in modulating these acute phase proteins in pigs (Figure 2).  
Body composition including lean and fat tissue between pigs from different dietary 
treatments at the outcome of the present study did not differ except for low fat fed pigs were 
~1% less in total % body mass that was fat compared to pigs from the other diets (Table 5). This 
suggests the high fat diet did not drive the absorption of endotoxin, through increased bacterial 
translocation or otherwise, to generate obese body phenotypes as previously reported in mice 
fed an ultra-high fat corn oil and lard diet for 4 weeks (Table 5) (1). Although endotoxin has 
been indirectly-demonstrated to cause obesity through a CD14 dependent pathway in C57bl6/J 
mice given free access to an ultra-high fat diet made from corn oil and lard, conflicting evidence 
exists where in a separate study that did not measure endotoxin, the same mouse strain was 
fed the same corn oil and lard diet ad libitum for 9 months, and at the 3 month time point only 
2.6% of mice were deemed obese (1, 44).  
The translocation of Gram-negative bacteria across the epithelium has been 
demonstrated by several groups to proceed via a TLR4 dependent pathway (13, 45). Although 
previous evidence has shown ω3 fatty acids, including DHA and EPA, inhibit TLR4 activation in in 
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vitro cell culture, until now it was unknown if this mechanism translated to the intestine ex vivo 
(8). The significant reduction in E.coli translocation in jejunum segments, pretreated with 
ultrapure LPS (R. sphaeroides), a specific TLR4 competitive antagonist, from high fat diet but not 
high fat (with DHA/EPA) pigs suggests ω3 fatty acids prevent bacterial transcellular passage via 
modulation of TLR4 ex vivo. Moreover, jejunum from pigs fed high fat diet (with DHA/EPA) was 
significantly enriched in DHA/EPA at the outcome of the present study compared to tissues 
from animals that received the other diets (Table 4). Even without the use of the TLR4 inhibitor, 
tissue enriched in DHA/EPA had significantly less translocation of E.coli compared to tissues 
from other animal treatment groups (Table 5). The inability of methyl β-cyclodextrin, which 
sequesters cholesterol, to likewise reduce translocated bacteria may indicate TLR4 activation 
occurs independent of association with cellular cholesterol. 
Our results demonstrate the long-term consumption of a diet rich in DHA/EPA does 
modulate translocation of Gram-negative bacteria across the jejunum via a TLR4-dependent 
pathway. Importantly, increased passage across the intestinal epithelium was not associated 
with greater endotoxemia suggesting previous reports of a modulatory effect of a meal’s 
dietary fatty acid composition on postprandial blood endotoxin concentration may occur before 
physiological adjustment a new type of diet. The in-between period that defines a change in 
endotoxemia from the first meal until the outcome of long-term feeding where the 
endotoxemia difference is abolished, should be a focus of future research. 
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Tables 
Table 1. Diet composition, as fed 
Composition, % High fat High fat (with 
EPA/DHA) 
Low fat 
  Corn, yellow dent  46.71 46.71 59.78 
  Soybean meala 28.89 28.89 26.80 
  Soybean oil 7.30 7.30 3.60 
  Lard  14.60 7.30 7.30 
  Fish oil (Menhaden) 0.00 7.30 0.00 
  L-lysine HCl  0.04 0.04 0.06 
  DL-methionine  0.02 0.02 0.01 
  Monocalcium phosphate  0.88 0.88 0.88 
  Limestone 0.91 0.91 0.92 
  Salt  0.35 0.35 0.35 
  Trace Mineral and vitamin  
  premixe 
0.30 0.30 0.30 
      
Analyzed chemical composition    
  Total lipidb 23.38 ± 0.12 23.20 ± 0.10 11.07 ± 0.21 
  Energyc 5.25 ± 0.01 5.23 ± 0.01 4.71 ± 0.01 
  Endotoxind 258.38 ± 7.53 287.96 ± 9.38 280.88 ± 12.2 
a47.5% Crude protein   
b Total lipid content (mean ± SEM) based on duplicate lipid extracts of each diet; values 
expressed as % lipid of total weight of diet 
c Gross energy (mean ± SEM) determined from duplicate bombed samples of each diet; 
values expressed as kcal/g of diet (dry matter basis) 
d Diets were assayed in duplicate using the LAL kinetic chromogenic endotoxin assay; 
values (mean ± SEM) expressed as endotoxin units/g of diet  
ePremix supplied (per kg of diet): 8,820 IU vitamin A, 1,653 IU vitamin D3, 33.1 IU vitamin E, 4.4 
mg vitamin K, 6.6 mg riboflavin, 38.9 mg niacin, 22.1 mg pantothenic acid, 0.04 mg vitamin 
B12, .1 mg I as potassium iodide. 
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Table 2. Dietary fatty acid profiles*,1 
  High Fat (with 
DHA/EPA) 
High Fat Low Fat 
Fatty acid Common name    
8:0 Caprylic ND ND ND 
10:0 Capric 0.04±0.00 0.05 ± 0.00 0.03 ± 0.00 
12:0 Lauric 0.08 ± 0.00 0.05 ± 0.00 0.04 ± 0.00 
14:0 Myristic 3.57 ± 0.01 0.86 ± 0.02 0.71 ± 0.16 
16:0 Palmitic 17.24 ± 0.01 18.80 ± 0.19 17.59 ± 0.30 
16:1 Palmitoleic 4.88 ±0.02 1.24 ± 0.02 1.07 ± 0.02 
18:0 Stearic 6.28 ± 0.02 9.15 ± 0.06 7.70 ± 0.21 
18:1 ω9 cis Oleic 21.77 ± 0.00 30.81 ± 0.16 29.34 ± 0.11 
18:2 ω6 cis Linoleic 29.46 ± 0.04 33.06 ± 0.03 37.42 ± 0.52 
18:3 ω3  α-Linolenic 3.71 ± 0.00 3.21 ± 0.01 3.45 ± 0.06 
20:4 ω6 Arachidonic 0.02 ± 0.00 ND ND 
20:5 ω3 EPA 4.60 ± 0.00 ND ND 
22:5 ω3 DPA 0.72 ± 0.00 0.02 ± 0.00 0.01 ± 0.00 
22:6 ω3 DHA 3.22 ± 0.11 ND ND 
Other  4.35 ± 0.02 2.75 ± 0.07 2.64 ± 0.07 
ω6: ω3  2.33 ± 0.02 9.77 ± 0.02 10.42 ± 0.07 
Saturated  28.72 ± 0.00 30.10 ± 0.13 27.32 ± 0.54 
ω3  12.73 ± 0.09 3.39 ± 0.01 3.59 ± 0.07 
ω6   29.78 ± 0.04 33.18 ± 0.05 37.52 ± 0.49 
*All values are expressed mean ± SEM as % of total fatty acids from duplicate lipid extracts of 
each diet; values within the same row but with different superscript letters are significantly 
different at the p<0.05 level. 
1ND ; not detected 
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Table 3. Pig jejunum fatty acid profiles* 
  High Fat (with 
DHA/EPA) 
High Fat Low Fat 
Fatty acid Common name    
14:0 Myristic 1.40 ± 0.95 1.82 ± 0.81 0.90 ± 0.23 
16:0 Palmitic 21.33 ± 0.45 21.52 ± 0.57 23.04 ± 1.19 
16:1 Palmitoleic 1.43 ± 0.40 0.56 ± 0.06 0.81 ± 0.11 
18:0 Stearic 17.15 ± 0.68 17.42 ± 0.50 19.00 ± 1.04 
18:1 ω9 cis Oleic 16.52 ± 0.77 18.28 ± 0.45 21.20 ± 1.95 
18:2 ω6 cis Linoleic 23.30 ± 1.67 28.00 ± 0.96 24.99 ± 1.68 
18:3 ω3  α-Linolenic 1.54 ± 0.27 1.35 ± 0.10 1.31 ± 0.02 
20:4 ω6 Arachidonic 4.74 ± 0.93 8.01 ± 0.51 6.68 ± 1.24 
20:5 ω3 EPA a5.55 ± 0.56 b0.48 ± 0.09 b0.44 ± 0.35 
22:5 ω3 DPA 2.94 ± 0.53 1.45 ± 0.02 1.14 ± 0.24 
22:6 ω3 DHA a4.09 ± 0.30 b1.11 ± 0.32 b0.45 ± 0.45 
ω6: ω3  1.98 ± 0.42 8.19 ± 1.71 9.46 ± 1.88 
Saturated  39.89 ± 1.18 40.76 ± 0.76 42.94 ± 1.95 
ω3  14.12 ± 0.97 4.39 ± 0.26 3.34 ± 0.97 
ω6  28.04 ± 0.95 36.01 ± 0.73 31.67 ± 2.93 
*All values are expressed mean ± SEM as % of total fatty acids from duplicate lipid extracts of 
each diet or jejunum tissue (n=5 pigs per diet); values within the same row but with different 
superscript letters are significantly different at the p<0.05 level. 
 
Table 4. Ex vivo bacterial translocation across porcine jejunum epithelium*,1,2  
Diet Control LPS-RS MβCD Main effects Interaction 
    Diet RS-LPS  
High fat 
(DHA/EPA) 
375 ± 69b 229 ± 58 587 ± 141 p<0.001 
Diet 
p<0.001 
 MβCD 
p<0.001 
High fat 1491 ± 122a 302 ± 57b 969 ± 181 p<0.001 p=0.605 p=0.005 
Low fat 188 ± 56b 84 ± 27 350 ± 178    
* All values are expressed as mean ± SEM. Values expressed as CFU/mL or EU/mL 
1 Pig jejunum segments mounted in Ussing chambers were incubated without (n=12 
jejunum/diet) or with (n=6 jejunum/diet) 10 µg/mL ultrapure LPS R. sphaeroides (LPS-RS) or (n=6 
jejunum/diet) 25mM methyl β-cyclodextrin (MβCD) as described in Methods. Mounted tissues 
were then challenged on the mucosal side with T E. coli K-12. At 75 min, serosal chamber 
content was collected, immediately spread-plated and grown overnight before quantitation of 
bacterial CFU 
2 Values within the same row, or within the same column, but with different superscript 
characters are different at p<0.05 level 
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Table 5. Effects of dietary fat on pig body composition and tissue accretion  
Parameter Low fat High fat High fat (with 
DHA/EPA) 
SEM p-value 
Initial Body 
Composition 
     
Total mass, kg 55.9 56.6 56.7 2.62 0.972 
BMC, kg 1.41 1.42 1.36 0.098 0.855 
BMD, g/cm2 0.84 0.84 0.83 0.014 0.728 
Lean mass, kg 45.1 46.3 45.6 1.88 0.913 
Fat mass, kg 8.2 7.9 8.5 0.77 0.861 
Fat, % 17.2 16.6 16.9 0.43 0.624 
Final Body 
Composition 
     
Total mass, kg 119.7 121.5 117.0 3.63 0.681 
BMC, kg 3.20 3.17 3.19 0.121 0.984 
BMD, g/cm2 1.04 1.03 1.04 0.022 0.772 
Lean mass, kg 91.9 91.4 88.4 2.61 0.593 
Fat mass, kg 21.7 23.8 22.5 0.91 0.271 
Fat, % 20.6a 22.3b 21.9ab 0.34 0.006 
Whole Body 
Tissue Accretion 
     
Total mass, g/day 1042 1059 985 30.5 0.219 
BMC, g/day 29.3 28.6 29.7 1.27 0.827 
Lean mass, g/day 765 738 699 20.2 0.095 
Fat mass, g/day 221a 260b 229ab 10.4 0.036 
1Whole body tissue accretion rate over a 63 day test period; BMC, bone mineral content; 
BMD, bone mineral density.  Values with different superscript letters within the same row 
are statistically different at p<0.05 level. 
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Figure 1. Changes in fasted and fed serum endotoxin (EU/mL) in pigs fed either a Low fat (LF), 
High fat (HF) or High fat plus omega 3 fatty acids (N3) meal. Serum was collected before and 1 h 
following feeding of a 1kg treatment meal as described in Materials and Methods. Data 
represents n=12 pigs/treatment. Effect of treatment p=0.0341; effect of time p =0.3294; 
diet*time interaction p=0.7303. 
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Figure 2. Fasted pig serum haptoglobin (A), C-reactive protein (B), lipopolysaccharide binding 
protein (C), and fasted and fed pig serum insulin (D) according to treatment group at 9-week 
feeding study outcome. Results are expressed in mean ± SEM. Acute phase proteins or insulin 
were not significantly different (p>0.05) between treatment groups. 
 
155 
 
CHAPTER 6. GENERAL CONCLUSIONS 
Little is clear on the manipulation of endotoxemia through nutrition. This is particularly 
true because little, too, is understood regarding the etiology and significance of endotoxemia 
itself (1).  Dietary fat content, and to some extent, dietary fatty acid composition have been 
variably demonstrated within this dissertation to modulate blood endotoxin concentration 
during the postprandial phase, alter inflammatory response, and affect related aspects at the 
site of the small intestine, including bacterial translocation. Part of the difficulty in ascribing the 
implication(s), general or specific, to this phenomenon is that a quantitative standardized 
definition of endotoxemia (EU/mL in serum, plasma, or whole blood) does not exist primarily 
because there is no consensus on whether endotoxin is normally found in the bloodstream (2-
4). With this consideration in mind, this dissertation identified dietary lipids to modulate 
response to endotoxin in humans in vivo, pigs ex vivo, and porcine cell culture in vitro, 
presenting a potential translational model system to further examine the role and significance 
of lipid modulation of endotoxemia. 
Several reports have previously, to varying degrees, tied high fat consumption in 
humans, mice, and pigs to changes in postprandial endotoxemia (5-7). The association of a 
nutritionally-induced rise or fall in blood endotoxin concentration has also been tenuously 
linked with inflammation (5, 8). A tying theme that may explain such uneven conclusions is that 
the amount and type of dietary lipid, as well as its fatty acid composition, often differed 
substantially between relevant studies (6, 7). Hence, in Chapter 3, the goal of the investigation 
was to understand whether in people, changes in postprandial endotoxemia were related to 
low or high fat content of a meal, or if instead the effect was derived from the fatty acid 
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composition of the fat in the meal. It was found that postprandial endotoxemia was altered by 
the fatty acid composition of a meal insofar that meals rich in saturated or polyunsaturated n-3 
fatty acids were inversely related in their effects. Moreover, a low fat meal was not different 
from a corresponding high fat meal in eliciting changes in blood endotoxin during the 
postprandial phase. These results help illustrate that in evaluating whether dietary lipids 
modulate endotoxemia, at least in humans, methodological dissimilarity of the nutrient 
composition of a meal or diet may have significant consequence on a study’s conclusion. Similar 
to the findings of several separate reports, we did not find an association between 
endotoxemia and inflammation in vivo. Per the relationship between dietary-induced 
endotoxemia and inflammation, what may be drawn from this study is that in healthy male and 
female adults postprandial endotoxemia may not be significant enough to generate a 
measurable immune response. However, even studies that separately assessed postprandial 
endotoxemia in morbidly obese and cigarette smoker populations, respectively, did not find a 
rise in inflammation to accompany an increase in endotoxemia in vivo (5, 8).  
Endotoxin has been evidenced to elicit an inflammatory response at the intestinal 
epithelium (9, 10). To this effect, we investigated whether common dietary fatty acids 
modulate this immune response and whether this modulation coincides with endotoxin 
passage across the gut epithelium. As such, we utilized the porcine small intestinal epithelial 
cell line, IPEC-J2, which forms a polarized epithelium in vitro to study the mechanism by which 
common dietary fatty acids might modulate endotoxin-induced inflammation and to evaluate 
whether this is related to endotoxin transport (11).  A flurry of previous studies have reported 
on the ability of fatty acids to influence TLR4 signaling (12-14).  Much of this work has 
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suggested a general division of saturated and polyunsaturated fatty acids in effecting activation 
and inhibition of TLR4, respectively. Although the principal MAMP receptor of endotoxin is 
TLR4, we did not observe a comparative increase in inflammatory cytokine production from co-
incubation of saturated fatty acids and endotoxin, compared to endotoxin alone. Conversely, a 
clear inhibitory effect on inflammatory response to endotoxin was observed following 
incubation of cells with polyunsaturated fatty acids. However, endotoxin was not observed to 
cross the in vitro epithelium under any condition. The anti-inflammatory effect of 
polyunsaturated, in particular n-3, fatty acids to intravenous or intraperitoneal endotoxin 
challenge is well-described in multiple in vivo, often murine, studies (15, 16).  That the results 
from Chapter 4 demonstrate this nutritional effect to likewise exert anti-inflammatory action at 
the site of the gut epithelium suggests a possible role for diets that contain polyunsaturated 
fatty acids to represent a preventive or therapeutic modality of intestinal inflammation that 
might result from epithelial exposure to endotoxin absorbed from the lumen. 
It is widely assumed that the increase in blood endotoxin concentration during the 
postprandial phase is derived from uptake of endotoxin from the intestinal lumen (17, 18). 
However, mechanistic evidence by which this phenomenon may proceed largely rests on a 
limited number of studies that utilize chemically purified LPS (19). Since chemically-purified LPS 
does not exist in vivo, we investigated in Chapter 5 whether uptake of live Gram-negative 
bacteria from the gut represents a viable avenue for LPS appearance in the bloodstream. 
Several studies before our own have suggested intestinal translocation of Gram negative 
bacteria but not LPS, is responsible for endotoxemia (20). Our study was the first to specifically 
address dietary fatty acid modulation of bacterial translocation in relation to endotoxemia. Like 
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previous studies, we found no evidence of chemically-purified LPS crossing the epithelium of 
porcine jejunum segments mounted in Ussing chambers.  Although we observed a high fat diet 
increased bacterial translocation while DHA/EPA addition to the same high fat diet significantly 
attenuated this effect, 9 week consumption of these diets by pigs did not associate blood 
endotoxin concentration in vivo with ex vivo bacterial translocation. However, this lack of 
association is highly representative of the medical literature in which even Gram negative 
bacteremia is infrequently accompanied by endotoxemia. These results suggest fatty acid 
composition of diets does have a modulatory effect at the intestinal epithelium but the effect 
on endotoxemia, commonly seen following a single meal, may not continue long-term. 
Taken together, this dissertation forms a translational framework within which future 
questions exploring the relationship between dietary lipid and endotoxemia may be tested. 
One particular avenue of interest would be to investigate how diet variation that contains 
either occasional or supplemental DHA/EPA or fatty acids influences postprandial endotoxemia 
or aspects of the intestinal epithelium. A significant obstacle in translating outcomes of animal 
studies to humans is that typically animals, including the long-term pig study in this 
dissertation, are fed the same meal every day for the study’s duration. This problem is found 
throughout the relevant literature, including several notable murine studies (6). Human diets 
are typically varied, can contain multiple different types of food consumed at different times 
each day and in distinct combinations (21). Designing a study to determine the effect of 
different dietary fatty acids in altering postprandial endotoxemia or related aspects under 
conditions considerate of human dietary variation would make for a promising translational 
study well-suited to the physiological similarity of the pig. This might be then translated into a 
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study in which human participants are recruited and provided a unique meal for each day of the 
week to evaluate the same outcomes. 
A second potential research question that might fit nicely in this context is the 
determination of whether native, not purified, LPS crosses the small intestinal epithelium in 
vivo. A major problem in the relevant literature is that it is unknown if native forms of LPS when 
consumed in the diet cross the epithelium to contribute to blood endotoxin concentration. 
Studies that report increased endotoxemia after meals have so far claimed without direct 
evidence that endotoxin is absorbed from that found in diet, or perhaps that found in the gut. 
Instead, the use of lysed or sonicated bacteria, such as E. coli K-12 that has had tritium 
incorporated into its lipid A as a live bacterium would provide bacterial membrane fragments in 
which LPS is found (22). Mixing of small amounts of native tritium labelled LPS into a meal, then 
fed to pigs, would allow for blood sampling to look for the appearance of the labelled-LPS in the 
bloodstream in vivo.  
Although the bulk of studies have evaluated the effect of dietary fatty acids on 
postprandial endotoxemia in healthy or obese populations, it would be of interest to examine 
population subsets in which the intestinal epithelium is damaged, such as irritable bowel 
disease patients. As patients with diseases under the umbrella of IBD may present with thinned 
mucosal layers, inflammation, and other symptoms, the role of dietary fatty acids in modulating 
inflammation and bacterial translocation at the intestinal epithelium might be of medical 
interest. The comparative physiological similarity of the gut between pig and human may allow 
for initial study to be performed in the pig, and results translated into human trials. 
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In conclusion, this dissertation presented novel evidence for the role of common dietary 
fatty acids in affecting endotoxemia, inflammation, and bacterial translocation. 
Polyunsaturated fatty acids, including DHA and EPA appear to have a translational impact in 
attenuating these outcomes variously in people, pigs, and porcine cell culture. The impact of 
nutrition in addressing health is increasingly recognized as the overlap between nutrition and 
immunology is increasingly blurred. The present research will contribute to further 
understanding the translational field of nutritional immunology. 
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